{
  "meta": {
    "title": "41_Pharmacokinetics",
    "url": "https://brainandscalpel.vercel.app/41-pharmacokinetics-6aca8976.html",
    "scrapedAt": "2025-11-30T06:59:59.368Z"
  },
  "questions": [
    {
      "id": 89077,
      "choices": [
        {
          "id": 256916,
          "text": "Isoprenaline"
        },
        {
          "id": 256917,
          "text": "Lignocaine"
        },
        {
          "id": 256918,
          "text": "Testosterone"
        },
        {
          "id": 256919,
          "text": "Verapamil"
        }
      ],
      "text": "Which of the following drug undergo high first pass metabolism so given at high dose orally is",
      "unique_key": "Q2034973",
      "question_audio": null,
      "question_video": null,
      "map_id": 34197120,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Verapamil Verapamil undergoes extensive first-pass metabolism in the liver, which significantly reduces its bioavailability when taken orally. First-pass metabolism refers to the breakdown of a drug in the liver before it reaches systemic circulation. Due to this high hepatic metabolism, a much higher oral dose is required compared to its intravenous form to achieve therapeutic plasma levels. Verapamil is a calcium channel blocker primarily used to treat hypertension, angina, and arrhythmias. When taken orally, nearly 80-90% of the drug is metabolized before reaching circulation, necessitating a higher dosage to compensate for this loss. Incorrect Options: A) Isoprenaline – Incorrect Isoprenaline (isoproterenol) is a beta-adrenergic agonist used primarily for treating bradycardia and heart block. It has a short half-life due to rapid metabolism by catechol-O-methyltransferase (COMT), but it is not highly affected by first-pass metabolism to the extent that it requires a significantly higher oral dose. Moreover, it is rarely given orally due to its rapid degradation. B) Lignocaine – Incorrect Lignocaine (lidocaine) is a local anesthetic and antiarrhythmic that undergoes extensive first-pass metabolism, making oral administration ineffective. However, because of this, it is not given orally at all, but rather administered intravenously or topically to bypass the liver metabolism. C) Testosterone – Incorrect Testosterone undergoes substantial first-pass metabolism, which limits its effectiveness when taken orally. However, rather than being administered at a higher oral dose, alternative delivery methods such as transdermal patches, injections, or sublingual formulations are preferred to bypass the hepatic metabolism. Hence, while testosterone does undergo significant first-pass metabolism, it is not given at high doses orally due to its low bioavailability.",
      "correct_choice_id": 256919,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62539661700309929/62539661700309929.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62539661700309929/62539661700309929.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89078,
      "choices": [
        {
          "id": 256920,
          "text": "Unpalatable drugs can’t be given"
        },
        {
          "id": 256921,
          "text": "Absorption of drugs may be variable and erratic"
        },
        {
          "id": 256922,
          "text": "Not useful in emergencies"
        },
        {
          "id": 256923,
          "text": "Drugs with high first pass metabolism can be given"
        }
      ],
      "text": "Following are true about oral route of drug administration EXCEPT",
      "unique_key": "Q7552963",
      "question_audio": null,
      "question_video": null,
      "map_id": 34080282,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Drugs with high first-pass metabolism can be given Drugs that undergo high first-pass metabolism are not ideal for oral administration because they are extensively metabolized by the liver before reaching systemic circulation. This significantly reduces their bioavailability, making them less effective when given orally. Examples include propranolol, verapamil, nitroglycerin, and lignocaine. For such drugs, alternative routes like sublingual, intravenous, or transdermal administration are preferred to bypass hepatic metabolism and improve therapeutic efficacy. Although some drugs with high first-pass metabolism (e.g., propranolol, verapamil) can still be given orally, they require much higher doses to achieve the desired effect, which is not always practical. Incorrect Options: A) Unpalatable drugs can’t be given – Incorrect While unpalatable drugs (bitter or unpleasant-tasting medications) are difficult to administer orally, they can still be given using flavoring agents, enteric-coated tablets, or capsules to mask the taste. For example, liquid formulations of some antibiotics are sweetened to improve compliance in children. Thus, unpalatable drugs can be administered orally with modifications. B) Absorption of drugs may be variable and erratic – Correct but not the exception The oral route is associated with variable drug absorption due to factors such as food intake, gastric pH, enzyme activity, and gut motility. Certain drugs may have erratic absorption, especially if they are poorly soluble, unstable in acidic conditions, or affected by interactions with food or other drugs. For example, tetracyclines bind to calcium in dairy products, reducing their absorption. This variability makes oral administration less predictable compared to intravenous administration. C) Not useful in emergencies – Correct but not the exception In emergency situations, the oral route is not preferred because it is slow in onset due to the time required for drug absorption and metabolism. In contrast, intravenous, intramuscular, or sublingual routes provide a much faster onset of action. For instance, in acute myocardial infarction, sublingual nitroglycerin is used instead of oral forms to achieve rapid vasodilation.",
      "correct_choice_id": 256923,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63885811700309955/63885811700309955.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63885811700309955/63885811700309955.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89079,
      "choices": [
        {
          "id": 256924,
          "text": "Hepatic blood flow multiplied by Vd"
        },
        {
          "id": 256925,
          "text": "Hepatic clearance divided by hepatic blood flow"
        },
        {
          "id": 256926,
          "text": "Hepatic blood flow multiplied by hepatic clearance"
        },
        {
          "id": 256927,
          "text": "Hepatic blood flow multiplied by bioavailability"
        }
      ],
      "text": "Hepatic extraction ratio is given by",
      "unique_key": "Q3826774",
      "question_audio": null,
      "question_video": null,
      "map_id": 34796953,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hepatic clearance divided by hepatic blood flow The hepatic extraction ratio (E) is a measure of the liver’s efficiency in removing a drug from the blood during its first pass through the liver. It is defined as: Extraction ratio = Hepatic Clearance (Clh)/Hepatic Blood Flow (Qh) represents the volume of blood from which the drug is completely removed by the liver per unit time. Hepatic blood flow (Qh) is the total volume of blood passing through the liver per unit time (~1.5 L/min in a healthy adult). If a drug has a high extraction ratio (E close to 1), it means that most of the drug is removed during its first pass through the liver (e.g., propranolol, morphine). If a drug has a low extraction ratio (E close to 0), it means the liver removes only a small fraction of the drug from circulation (e.g., warfarin, diazepam). Incorrect Options: A) Hepatic blood flow multiplied by volume of distribution (Vd) – Incorrect Hepatic blood flow (Qh) determines the delivery of the drug to the liver, and volume of distribution (Vd) represents how the drug is distributed in the body. However, Vd is unrelated to hepatic extraction, as it describes drug distribution rather than elimination. This formula does not define hepatic extraction ratio. C) Hepatic blood flow multiplied by hepatic clearance – Incorrect Multiplying hepatic blood flow (Qh) by hepatic clearance (Clh) does not provide a meaningful ratio. Instead, it would give a rate-related term rather than a unitless extraction ratio. The correct relationship involves dividing hepatic clearance by blood flow, not multiplying them. D) Hepatic blood flow multiplied by bioavailability – Incorrect Bioavailability (F) refers to the fraction of the drug that reaches systemic circulation unchanged and is affected by both hepatic and intestinal metabolism. However, multiplying hepatic blood flow (Qh) by bioavailability (Fh) does not yield the extraction ratio. Instead, the relationship between bioavailability and extraction ratio is given by: F=1-E",
      "correct_choice_id": 256925,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2197291700309976/2197291700309976.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2197291700309976/2197291700309976.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89080,
      "choices": [
        {
          "id": 256928,
          "text": "Edema"
        },
        {
          "id": 256929,
          "text": "Ascites"
        },
        {
          "id": 256930,
          "text": "Pleural effusion"
        },
        {
          "id": 256931,
          "text": "All of the above"
        }
      ],
      "text": "Gentamicin volume of distribution is increased in following condition",
      "unique_key": "Q3139132",
      "question_audio": null,
      "question_video": null,
      "map_id": 34870625,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All of the above The volume of distribution (Vd) of a drug refers to the theoretical volume in which the drug is distributed throughout the body. Gentamicin is an aminoglycoside antibiotic that is hydrophilic (water-soluble) and primarily distributes into extracellular fluid (ECF), including plasma and interstitial fluid. Conditions such as edema, ascites, and pleural effusion increase the amount of extracellular fluid, thereby increasing the volume of distribution (Vd) of gentamicin. As a result: More drug distributes into the expanded fluid compartment. The plasma concentration of gentamicin decreases for a given dose. Higher doses of gentamicin may be required to achieve therapeutic plasma levels. Since all three conditions increase extracellular fluid volume, they all contribute to an increased Vd of gentamicin, making option D correct. Incorrect Options: A) Edema – Correct but not the only factor Edema refers to fluid accumulation in the interstitial space, which increases the extracellular fluid volume. Since gentamicin is distributed in extracellular fluid, its Vd increases in edematous states such as heart failure, nephrotic syndrome, or hypoalbuminemia. However, edema is just one factor; ascites and pleural effusion also contribute. B) Ascites – Correct but not the only factor Ascites is the accumulation of fluid in the peritoneal cavity, often seen in liver cirrhosis, malignancies, or tuberculosis. Since this fluid is part of the extracellular compartment, gentamicin can distribute into this space, increasing its Vd. However, ascites alone does not explain the full picture, as pleural effusion and edema also contribute. C) Pleural Effusion – Correct but not the only factor Pleural effusion is fluid accumulation in the pleural space, which can occur in conditions like pneumonia, malignancies, or congestive heart failure. Since gentamicin distributes in extracellular fluid, its Vd increases in pleural effusion as well. However, this is only one of the contributing conditions.",
      "correct_choice_id": 256931,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61579251700310105/61579251700310105.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61579251700310105/61579251700310105.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89081,
      "choices": [
        {
          "id": 256932,
          "text": "Total amount of drug in body divided by Drug clearance"
        },
        {
          "id": 256933,
          "text": "Total amount of drug in body divided by Drug half life"
        },
        {
          "id": 256934,
          "text": "Total amount of drug in body divided by elimination rate constant"
        },
        {
          "id": 256935,
          "text": "Total amount of drug in body divided by Drug Plasma Concentration"
        }
      ],
      "text": "Apparent volume of distribution is",
      "unique_key": "Q7456633",
      "question_audio": null,
      "question_video": null,
      "map_id": 34138260,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Total amount of drug in body divided by Drug Plasma Concentration The apparent volume of distribution (Vd) is a pharmacokinetic parameter that describes the extent to which a drug distributes in body tissues relative to the plasma. It is given by the formula: Vd = Total amount of drug in the body / Plasma drug concentration A high Vd indicates that the drug extensively distributes into tissues (e.g., lipophilic drugs like amiodarone). A low Vd suggests the drug remains largely in the plasma (e.g., hydrophilic drugs like aminoglycosides). Thus, option D is correct because the apparent volume of distribution is calculated by dividing the total drug amount by its plasma concentration. Incorrect Options: A) Total amount of drug in body divided by Drug clearance – Incorrect Clearance (CL) is the volume of plasma cleared of a drug per unit time, not a measure of drug distribution. The formula for clearance is: CL = Plasma concentration / Rate of elimination Since Vd is unrelated to clearance in this context, this option is incorrect. B) Total amount of drug in body divided by Drug half-life – Incorrect Half-life (t½) describes how long it takes for the drug concentration to reduce by 50% but does not determine the volume of distribution. Since Vd is not directly calculated using half-life, this option is incorrect. C) Total amount of drug in body divided by elimination rate constant – Incorrect The elimination rate constant (k) is related to clearance and half-life, and the formula involving k is: CL = k × Vd While Vd is related to k, it is not directly calculated by dividing the total drug amount by k. Hence, this option is incorrect.",
      "correct_choice_id": 256935,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66884841700310334/66884841700310334.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66884841700310334/66884841700310334.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89082,
      "choices": [
        {
          "id": 256936,
          "text": "Drugs with high molecular weight has less aVd"
        },
        {
          "id": 256937,
          "text": "aVd of >20L/kg means the drug has a large aVd"
        },
        {
          "id": 256938,
          "text": "Drugs with High aVd are difficult to remove by hemodialysis"
        },
        {
          "id": 256939,
          "text": "Drugs with aVd and high protein bound are known to cause less toxicity during displacement reactions"
        }
      ],
      "text": "The following are true about apparent volume of distribution except",
      "unique_key": "Q5526903",
      "question_audio": null,
      "question_video": null,
      "map_id": 34844323,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Drugs with aVd and high protein bound are known to cause less toxicity during displacement reactions Apparent Volume of Distribution (aVd) represents how extensively a drug distributes in body tissues compared to plasma. It is a theoretical volume that does not correspond to an actual physiological space but indicates the drug’s distribution characteristics. Drugs that are highly protein-bound and have a large Vd tend to accumulate in tissues. If a protein-bound drug is displaced (e.g., by another drug), the free drug concentration in plasma increases, leading to potential toxicity (e.g., warfarin displacement by NSAIDs). High protein binding does not necessarily reduce toxicity in displacement reactions; in fact, it can increase it by suddenly raising free drug levels in plasma. Since this statement is incorrect, option D is the correct answer. Incorrect Options: A) Drugs with high molecular weight have less aVd – Correct Drugs with high molecular weight (e.g., heparin) and high plasma protein binding stay mostly in the plasma, leading to a low Vd. These drugs are less likely to penetrate tissues, resulting in an aVd closer to plasma volume (~3-5 L in humans). Since this statement is true, this option is incorrect. B) aVd of >20 L/kg means the drug has a large aVd – Correct A Vd of >20 L/kg suggests extensive tissue distribution because the total body water is approximately 42 L in a 70 kg adult. Lipophilic drugs (e.g., amiodarone, digoxin) have large Vd values and distribute extensively into fat and tissues. Since this statement is true, this option is incorrect. C) Drugs with High aVd are difficult to remove by hemodialysis – Correct Hemodialysis is effective for drugs that stay in plasma (i.e., those with low Vd and low protein binding). Drugs with a high Vd distribute widely into tissues and are not easily removed (e.g., tricyclic antidepressants, amiodarone). Since this statement is true, this option is incorrect.",
      "correct_choice_id": 256939,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31097191700310345/31097191700310345.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31097191700310345/31097191700310345.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89083,
      "choices": [
        {
          "id": 256940,
          "text": "G protein"
        },
        {
          "id": 256941,
          "text": "Cyclic AMP"
        },
        {
          "id": 256942,
          "text": "Inositol trisphosphate"
        },
        {
          "id": 256943,
          "text": "Diacylglycerol"
        }
      ],
      "text": "Which of the following does not act as second messenger",
      "unique_key": "Q2895225",
      "question_audio": null,
      "question_video": null,
      "map_id": 34566960,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) G protein does not act as a second messenger Second messengers are intracellular signaling molecules that help transmit signals from extracellular receptors to target cellular responses. They amplify the signal initiated by the primary messenger (ligand or hormone) binding to a receptor. G proteins (Guanine nucleotide-binding proteins) are not second messengers; rather, they are intracellular transducers that relay signals from G-protein-coupled receptors (GPCRs) to second messengers. When a ligand binds to a GPCR, G proteins get activated and modulate the activity of enzymes like adenylate cyclase or phospholipase C, leading to the generation of second messengers. Since G proteins act upstream of second messengers rather than being one, they are not classified as second messengers. Thus, option A is correct because G proteins serve as signal transducers, not second messengers. Incorrect Options: B) Cyclic AMP (cAMP) – Incorrect cAMP is a well-known second messenger that is produced from ATP by the enzyme adenylate cyclase. It plays a crucial role in various signal transduction pathways, including those involving epinephrine, glucagon, and ACTH. cAMP activates protein kinase A (PKA), leading to various cellular responses. Since cAMP functions as a second messenger, this option is incorrect. C) Inositol trisphosphate (IP3) – Incorrect IP3 is a second messenger produced by the action of phospholipase C (PLC) on phosphatidylinositol 4,5-bisphosphate (PIP2). It helps in releasing calcium ions (Ca2+) from intracellular stores like the endoplasmic reticulum, leading to further cellular responses. Since IP3 is a second messenger, this option is incorrect. D) Diacylglycerol (DAG) – Incorrect DAG is another second messenger generated alongside IP3 from PIP2 cleavage by phospholipase C. It activates protein kinase C (PKC), which plays a role in various intracellular signaling pathways, including those regulating cell growth and metabolism. Since DAG acts as a second messenger, this option is incorrect.",
      "correct_choice_id": 256940,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10536721700310478/10536721700310478.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10536721700310478/10536721700310478.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89084,
      "choices": [
        {
          "id": 256944,
          "text": "Action on a membrane spanning tyrosine kinase"
        },
        {
          "id": 256945,
          "text": "Diffusion across the membrane and binding to an intracellular receptor"
        },
        {
          "id": 256946,
          "text": "Action of a G protein, which activates or inhibits adenylyl cyclase"
        },
        {
          "id": 256947,
          "text": "Opening of transmembrane ion channels"
        }
      ],
      "text": "Which of the following most accurately describes the transmembrane signaling process involved in the steroid hormone action",
      "unique_key": "Q4290038",
      "question_audio": null,
      "question_video": null,
      "map_id": 34765161,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Diffusion across the membrane and binding to an intracellular receptor Steroid hormones (such as cortisol, estrogen, and testosterone) act via intracellular receptors because they are lipophilic molecules. Their signaling process involves: Diffusion through the plasma membrane – Since steroid hormones are lipid-soluble, they can easily cross the lipid bilayer of the cell membrane. Binding to intracellular receptors – Inside the cell, they bind to specific cytoplasmic or nuclear receptors. Translocation to the nucleus – The hormone-receptor complex translocates into the nucleus and binds to hormone response elements (HREs) on DNA. Gene transcription and protein synthesis – This leads to the regulation of gene expression, resulting in long-lasting physiological effects. Since this mechanism is specific to steroid hormones, option B is the correct answer. Incorrect Options: A) Action on a membrane-spanning tyrosine kinase – Incorrect Tyrosine kinase receptors are involved in signal transduction for peptide hormones (e.g., insulin, growth factors) but not steroid hormones. These receptors span the membrane and get activated when a ligand binds extracellularly, leading to phosphorylation cascades inside the cell. Steroid hormones do not require membrane receptors since they diffuse freely through the lipid bilayer. C) Action of a G protein, which activates or inhibits adenylyl cyclase – Incorrect G-protein-coupled receptors (GPCRs) are typically used by peptide hormones (e.g., epinephrine, glucagon) to mediate rapid cellular responses via cAMP or IP3 pathways. Steroid hormones do not require second messengers like cAMP; instead, they exert direct genomic effects via nuclear receptors. D) Opening of transmembrane ion channels – Incorrect Ligand-gated ion channels (e.g., nicotinic receptors, GABA receptors) mediate the effects of neurotransmitters like acetylcholine and GABA. Steroid hormones do not act by modulating ion channel activity; they regulate gene expression inside the cell.",
      "correct_choice_id": 256945,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36074381700310543/36074381700310543.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36074381700310543/36074381700310543.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89085,
      "choices": [
        {
          "id": 256948,
          "text": "40 hr."
        },
        {
          "id": 256949,
          "text": "80 hr."
        },
        {
          "id": 256950,
          "text": "77 hr."
        },
        {
          "id": 256951,
          "text": "0.02 hr."
        }
      ],
      "text": "A volunteer Ram will receive a new drug in phase I clinical trial. The clearance and the volume of distribution of the drug in Ram are 1.386 L/hr. and 80 L respectively. The half-life of the drug in him would be approximately",
      "unique_key": "Q7127663",
      "question_audio": null,
      "question_video": null,
      "map_id": 34160354,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) 40 hr The half-life (t1/2) of a drug is calculated using the formula: t1/2 = 0.693 × Vd / Cl Where: • V_d = Volume of distribution = 80 L • Cl = Clearance = 1.386 L/hr • 0.693 is a constant (natural logarithm of 2) Substituting the values: t1/2 = 0.693 × 80 / 1.386 t1/2 = 55.44/1.386 ≈ 40hr Thus, the half-life of the drug is approximately 40 hours, making option A correct. ______________ Incorrect Options: B) 80 hr – Incorrect • If the half-life were 80 hours, this would imply either a much larger volume of distribution or a much lower clearance, neither of which match the given values. ______________ C) 77 hr – Incorrect • A half-life of 77 hours is an overestimation based on incorrect calculations. Using the correct formula, we obtained 40 hours. ______________ D) 0.02 hr – Incorrect • A half-life of 0.02 hours (1.2 minutes) would mean extremely rapid elimination, which is inconsistent with a large volume of distribution (80 L) and a relatively low clearance (1.386 L/hr).",
      "correct_choice_id": 256948,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/358741700310564/358741700310564.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/358741700310564/358741700310564.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89086,
      "choices": [
        {
          "id": 256952,
          "text": "Approximately 32 hrs"
        },
        {
          "id": 256953,
          "text": "Approximately 48 min"
        },
        {
          "id": 256954,
          "text": "Approximately 5.8 hrs"
        },
        {
          "id": 256955,
          "text": "Approximately 8 hrs"
        }
      ],
      "text": "A young male Kallu is brought to the hospital with severe asthma. The pharmacokinetics of theophylline include the following parameters: V4= 35 L; CL= 48 ml/min; half-life is 8 hrs. If an intravenous infusion of theophylline is started at the rate of 0.48 mg/min, how will it take to reach 93.75% of the final steady state",
      "unique_key": "Q2517525",
      "question_audio": null,
      "question_video": null,
      "map_id": 34981607,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Approximately 32 hours The time required to reach 93.75% of steady state depends on the half-life (t1/2) of the drug. Steady-state drug levels are achieved after approximately 4-5 half-lives. The percentage of steady-state reached at different multiples of half-life is: • 1 half-life = 50% • 2 half-lives = 75% • 3 half-lives = 87.5% • 4 half-lives = 93.75% Given that the half-life (t1/2) of theophylline = 8 hours, the time required to reach 93.75% of the final steady state is: 4 × t1/2 = 4 × 8 = 32 hours Thus, option (A) is correct as it takes approximately 32 hours to reach 93.75% of steady state. Incorrect Options: B) Approximately 48 min – Incorrect • This is far too short compared to the calculated time of 32 hours. Since the half-life is 8 hours, reaching steady-state within 48 minutes is not possible. C) Approximately 5.8 hrs – Incorrect • This is also too short. Even after one half-life (8 hours), only 50% of steady-state is reached, so 5.8 hours is insufficient to reach 93.75%. D) Approximately 8 hrs – Incorrect • After one half-life (8 hours), only 50% of steady-state is reached, which is far from 93.75% steady-state levels. Four half-lives (32 hours) are required, making this option incorrect.",
      "correct_choice_id": 256952,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48710081700310576/48710081700310576.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48710081700310576/48710081700310576.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89087,
      "choices": [
        {
          "id": 256956,
          "text": "1.6 Days"
        },
        {
          "id": 256957,
          "text": "3.2 Days"
        },
        {
          "id": 256958,
          "text": "2.4 Days"
        },
        {
          "id": 256959,
          "text": "4.8 Days"
        }
      ],
      "text": "A 30-year-old patient on digoxin therapy has developed digitalis toxicity. The plasma digoxin level is 4 ng/mL. Renal function is normal and the plasma half-life (t1/2) for digoxin in this patient is 1.6 days. How long should you withhold digoxin in order to reach a safer, yet probably therapeutic, level of 1 ng/mL?\"",
      "unique_key": "Q4798382",
      "question_audio": null,
      "question_video": null,
      "map_id": 34684849,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) 3.2 Days The time required to reduce plasma digoxin levels from 4 ng/mL to 1 ng/mL depends on the half-life (t1/2) of digoxin, which is 1.6 days in this patient. Since drug elimination follows first-order kinetics, each half-life reduces the drug concentration by 50%: After 1 half-life (1.6 days) ? 4 ng/mL ? 2 ng/mL After 2 half-lives (3.2 days) ? 2 ng/mL ? 1 ng/mL Thus, to lower the plasma digoxin level from 4 ng/mL to a safer level of 1 ng/mL, we need two half-lives (1.6 × 2 = 3.2 days). Therefore, digoxin should be withheld for approximately 3.2 days. Incorrect Options: A) 1.6 Days – Incorrect After 1 half-life (1.6 days), the plasma level will only decrease from 4 ng/mL to 2 ng/mL, which is still above the therapeutic range. C) 2.4 Days – Incorrect This is an incomplete elimination time. Since one half-life (1.6 days) reduces it to 2 ng/mL, but reaching 1 ng/mL requires another full half-life (3.2 days), 2.4 days is insufficient. D) 4.8 Days – Incorrect After 3 half-lives (4.8 days), the plasma digoxin level would drop even further, closer to 0.5 ng/mL, which might lead to subtherapeutic effects rather than achieving a safe therapeutic range.",
      "correct_choice_id": 256957,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40578841700310588/40578841700310588.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40578841700310588/40578841700310588.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89088,
      "choices": [
        {
          "id": 256960,
          "text": "0.5 L/hr"
        },
        {
          "id": 256961,
          "text": "5.0 L/hr"
        },
        {
          "id": 256962,
          "text": "20 L/hr"
        },
        {
          "id": 256963,
          "text": "2.0 L/hr"
        }
      ],
      "text": "Rate of elimination of a new drug is 20 mg/hr at a steady state plasma concentration of 10 mg/L, then its renal clearance will be",
      "unique_key": "Q8185213",
      "question_audio": null,
      "question_video": null,
      "map_id": 34328518,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) 2.0 L/hr Renal clearance (CL) is calculated using the formula: CL = Rate of Elimination (RE) /Plasma Drug Concentration (C) Given: • Rate of elimination (RE) = 20 mg/hr • Plasma concentration (C) = 10 mg/L CL = 20 mg/hr10 mg/LC CL = 2.0 L/hr Thus, the correct answer is (D) 2.0 L/hr. ______________ Incorrect Options: A) 0.5 L/hr – Incorrect • This value is too low and does not match the calculated clearance. It may result from an incorrect division or misinterpretation of the formula. ______________ B) 5.0 L/hr – Incorrect • This is an overestimation. If clearance were 5 L/hr, the drug would be eliminated at a faster rate than calculated. ______________ C) 20 L/hr – Incorrect • This would imply that the drug is cleared at a rate of 20 mg/hr at a plasma concentration of 1 mg/L, which is not the given case.",
      "correct_choice_id": 256963,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10288511700310607/10288511700310607.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/10288511700310607/10288511700310607.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89089,
      "choices": [
        {
          "id": 256964,
          "text": "Total body clearance"
        },
        {
          "id": 256965,
          "text": "Volume of distribution"
        },
        {
          "id": 256966,
          "text": "Half life"
        },
        {
          "id": 256967,
          "text": "Lipid soluble"
        }
      ],
      "text": "Maintenance dose rate of a drug depends primarily on",
      "unique_key": "Q8931289",
      "question_audio": null,
      "question_video": null,
      "map_id": 34811686,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Total body clearance The maintenance dose rate is the rate at which a drug must be administered to maintain a steady plasma concentration. It is primarily determined by total body clearance (CL) because clearance represents the efficiency with which a drug is removed from the body. The formula for the maintenance dose rate is: Maintenance dose rate = Clearance × Target Plasma Concentration Maintenance dose rate=Clearance×Target Plasma Concentration Since clearance dictates how quickly the drug is removed, it directly influences how frequently and at what dose a drug needs to be administered to maintain steady-state levels. Therefore, total body clearance is the primary determinant of the maintenance dose rate. Incorrect Options: B) Volume of distribution – Incorrect Volume of distribution (Vd) determines the initial loading dose, not the maintenance dose. A larger Vd means more drug is distributed into tissues, affecting peak plasma concentration but not the steady-state maintenance dose. C) Half-life – Incorrect Half-life (t1/2) influences dosing interval but does not directly determine the maintenance dose rate. It is related to how long the drug stays in the system but is secondary to clearance in calculating maintenance dose. D) Lipid Solubility – Incorrect Lipid solubility affects drug distribution and ability to cross membranes but does not directly dictate maintenance dosing. While lipid-soluble drugs may have a high Vd, their clearance depends on metabolism and elimination, which are more relevant to determining maintenance dose rates.",
      "correct_choice_id": 256964,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42951951700310657/42951951700310657.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42951951700310657/42951951700310657.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89090,
      "choices": [
        {
          "id": 256968,
          "text": "100 L"
        },
        {
          "id": 256969,
          "text": "60 L"
        },
        {
          "id": 256970,
          "text": "50 L"
        },
        {
          "id": 256971,
          "text": "80 L"
        }
      ],
      "text": "Amount of a drug X administered to a patient is 4.0 g and its plasma concentration is found to be 50 ug/ml, what will be the volume of distribution of drug X?",
      "unique_key": "Q7995707",
      "question_audio": null,
      "question_video": null,
      "map_id": 34705871,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) 80 L The volume of distribution (Vd) is a pharmacokinetic parameter that represents the extent to which a drug is distributed throughout the body relative to the plasma concentration. It is calculated using the formula: Vd = Total dose administered/Plasma concentration Given: • Dose (D) = 4.0 g = 4000 mg • Plasma concentration (C) = 50 µg/mL = 0.05 mg/mL Since 1 L = 1000 mL, we convert plasma concentration into L: 0.05 mg/mL=50 mg/L0.05 \\text{ mg/mL} = 50 \\text{ mg/L}0.05 mg/mL=50 mg/L Now, applying the formula: Vd = 4000 mg/50 mg/LV Vd = 80L Thus, the correct answer is (D) 80 L. ______________ Incorrect Options: A) 100 L – Incorrect • This would result if the plasma concentration was lower than 50 µg/mL, leading to an overestimation of Vd. However, the actual calculated value is 80 L, making 100 L an overestimation. B) 60 L – Incorrect • A Vd of 60 L would mean the plasma concentration is higher than calculated. This underestimates the actual drug distribution in the body. C) 50 L – Incorrect • This is a lower value than the actual calculation. Since the drug is more widely distributed, 50 L is not accurate.",
      "correct_choice_id": 256971,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55728621700310673/55728621700310673.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55728621700310673/55728621700310673.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89091,
      "choices": [
        {
          "id": 256972,
          "text": "Administration of a bronchodilator drug by inhaled aerosol is usually associated with more adverse effects than administration of this drug by mouth."
        },
        {
          "id": 256973,
          "text": "Bioavailability of most drugs is greater with rectal administration than with sublingual administration"
        },
        {
          "id": 256974,
          "text": "Administration of a drug by transdermal patch is often faster but is associated with more first pass metabolism than oral administration"
        },
        {
          "id": 256975,
          "text": "The first pass effect is the result of elimination of a drug after administration and before it enters systemic circulation."
        }
      ],
      "text": "A patient, Rajesh with a history of wheezing, coughing and shortness of breath is being evaluated in the asthma clinic. Several drug treatments with different routes are under consideration. Which of the following statements about routes of administration is most correct?",
      "unique_key": "Q1135160",
      "question_audio": null,
      "question_video": null,
      "map_id": 34933708,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) The first-pass effect is the result of elimination of a drug after administration and before it enters systemic circulation. The first-pass effect (also called first-pass metabolism) refers to the process where a drug is significantly metabolized in the liver and gastrointestinal tract before reaching systemic circulation. This primarily occurs with oral drugs, as they must pass through the liver via the portal vein before distribution. As a result, the bioavailability of certain drugs is reduced when taken orally. For example, propranolol, nitroglycerin, and morphine undergo extensive first-pass metabolism, leading to reduced systemic drug levels when administered orally. Incorrect Options: A) Administration of a bronchodilator drug by inhaled aerosol is usually associated with more adverse effects than administration of this drug by mouth – Incorrect Inhalation is actually preferred for bronchodilators (e.g., salbutamol) as it directly targets the lungs and minimizes systemic absorption, leading to fewer adverse effects than oral administration. Oral bronchodilators have higher systemic effects, increasing the risk of tachycardia, tremors, and palpitations. B) Bioavailability of most drugs is greater with rectal administration than with sublingual administration – Incorrect Sublingual administration (e.g., nitroglycerin) bypasses first-pass metabolism and rapidly enters systemic circulation, leading to higher bioavailability than rectal administration. Rectal administration (e.g., suppositories) undergoes partial first-pass metabolism through the hepatic portal system, making its bioavailability lower than sublingual administration. C) Administration of a drug by transdermal patch is often faster but is associated with more first-pass metabolism than oral administration – Incorrect Transdermal administration allows slow and sustained drug release into the systemic circulation, leading to delayed onset of action (not faster). It bypasses first-pass metabolism, unlike oral drugs, which are extensively metabolized by the liver before entering circulation.",
      "correct_choice_id": 256975,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43329381700310690/43329381700310690.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43329381700310690/43329381700310690.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89092,
      "choices": [
        {
          "id": 256976,
          "text": "Urinary excretion would be accelerated by administration of NaHCO3 an alkalinizing agent"
        },
        {
          "id": 256977,
          "text": "More of the drug would be ionized at blood pH than at stomach pH"
        },
        {
          "id": 256978,
          "text": "Absorption of the drug would be faster from the stomach than from the small intestine."
        },
        {
          "id": 256979,
          "text": "Urinary excretion would be accelerated by administration of NH4 C1, an acidifying agent"
        }
      ],
      "text": "A three-year-old child is brought to the emergency department having just ingested a large overdose of an antihistaminic drug. This drug is a weak base capable of entering most tissues including the brain. On physical examination the heart rate is 100/7 minute, blood pressure is 110/60 mm Hg and the respiratory rate is 20/minute. In this case of poisoning",
      "unique_key": "Q1456865",
      "question_audio": null,
      "question_video": null,
      "map_id": 34922949,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent. The antihistaminic drug in this case is a weak base, meaning its excretion depends on the pH of the urine. Acidification of urine (using NH4Cl) helps in the ionization of weakly basic drugs, preventing their reabsorption in the renal tubules and enhancing excretion. This is known as ion trapping, where the charged (ionized) form of the drug is less likely to cross membranes and is therefore excreted more readily. In cases of weak base drug toxicity, acidifying urine enhances elimination and helps in faster detoxification. Incorrect Options: (A) Urinary excretion would be accelerated by administration of NaHCO3, an alkalinizing agent – Incorrect Sodium bicarbonate (NaHCO3) alkalinizes urine, which would reduce the ionization of a weak base drug, promoting its reabsorption rather than elimination. Alkalinization of urine is useful for weak acids (e.g., aspirin poisoning) but not for weak bases like antihistamines. (B) More of the drug would be ionized at blood pH than at stomach pH – Incorrect A weak base is more ionized in acidic environments (like the stomach, pH ~1.5-3.5) and less ionized in neutral to basic environments (like blood, pH ~7.4). In blood (higher pH), the drug remains more non-ionized, facilitating tissue penetration, including the brain. Thus, the statement is incorrect, as the drug would be more ionized in the stomach than in the blood. (C) Absorption of the drug would be faster from the stomach than from the small intestine – Incorrect Weak bases are poorly absorbed in the acidic stomach (because they remain ionized in low pH). They are absorbed more efficiently in the small intestine, where the higher pH (~5-7) allows the drug to remain non-ionized, facilitating better absorption. Therefore, this statement is incorrect.",
      "correct_choice_id": 256979,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37288591700310705/37288591700310705.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/37288591700310705/37288591700310705.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89093,
      "choices": [
        {
          "id": 256980,
          "text": "Lipid solubility"
        },
        {
          "id": 256981,
          "text": "Degree of ionization"
        },
        {
          "id": 256982,
          "text": "Rate of tubular secretion"
        },
        {
          "id": 256983,
          "text": "Plasma protein binding"
        }
      ],
      "text": "Which of the following factors has maximum effect on filtration of a drug by the glomerulus",
      "unique_key": "Q2382250",
      "question_audio": null,
      "question_video": null,
      "map_id": 34341516,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Plasma protein binding Glomerular filtration primarily depends on the free (unbound) drug concentration in plasma. Drugs that are highly bound to plasma proteins (such as albumin) cannot pass through the glomerular filter, significantly reducing their filtration rate. Only the unbound (free) fraction of the drug is available for filtration, making plasma protein binding the most significant factor affecting glomerular filtration. A drug with high plasma protein binding will have lower renal clearance via glomerular filtration compared to a drug with low binding. Incorrect Options: (A) Lipid solubility – Incorrect Lipid solubility does not significantly affect glomerular filtration because the filtration process is passive and size-dependent. Both lipid-soluble and water-soluble drugs that are not protein-bound can be filtered freely. Lipid solubility is more relevant to tubular reabsorption, where lipid-soluble drugs can be reabsorbed into circulation, reducing their excretion. (B) Degree of ionization – Incorrect The degree of ionization influences renal tubular reabsorption rather than glomerular filtration. Ionized (charged) drugs are less likely to be reabsorbed in renal tubules, leading to increased excretion, but this does not directly impact filtration at the glomerulus. (C) Rate of tubular secretion – Incorrect Tubular secretion is an active transport process occurring in the proximal tubule, independent of glomerular filtration. It involves carrier-mediated transporters that actively pump drugs from blood into urine, which is separate from passive glomerular filtration.",
      "correct_choice_id": 256983,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24831451700310746/24831451700310746.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24831451700310746/24831451700310746.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89094,
      "choices": [
        {
          "id": 256984,
          "text": "High plasma protein binding decreases the volume of distribution"
        },
        {
          "id": 256985,
          "text": "Volume of distribution of the drug is very high"
        },
        {
          "id": 256986,
          "text": "This drug will be filtered quickly by glomerulus"
        },
        {
          "id": 256987,
          "text": "This drug is likely to have minimum chances of drug interactions"
        }
      ],
      "text": "Which of the following statements about a drug having high plasma protein binding is true?",
      "unique_key": "Q9465240",
      "question_audio": null,
      "question_video": null,
      "map_id": 34906914,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) High plasma protein binding decreases the volume of distribution A drug with high plasma protein binding primarily binds to albumin (for acidic drugs) or α1-acid glycoprotein (for basic drugs) in the bloodstream. Since only the free (unbound) drug is available for distribution into tissues, a drug that is highly bound to plasma proteins remains confined to the intravascular compartment, resulting in a lower volume of distribution (Vd). For example, warfarin, phenytoin, and propranolol have high plasma protein binding and consequently exhibit a low Vd, meaning they largely stay within the plasma rather than distributing widely into body tissues. Incorrect Options: (B) Volume of distribution of the drug is very high – Incorrect A drug with high plasma protein binding remains mostly in the blood rather than distributing into tissues, leading to a low Vd. In contrast, drugs with low plasma protein binding have a higher Vd, as they easily distribute into tissues and fat compartments. Example: Digoxin, which has low plasma protein binding but high tissue binding, has a very high Vd (~7 L/kg). (C) This drug will be filtered quickly by glomerulus – Incorrect Only the free (unbound) fraction of a drug is filtered by the glomerulus. Since a highly protein-bound drug is mostly attached to albumin, it cannot pass through the glomerular filtration membrane, leading to slower renal clearance. Example: Warfarin (99% bound to plasma proteins) is poorly filtered by the kidneys. (D) This drug is likely to have minimum chances of drug interactions – Incorrect Highly protein-bound drugs have a high potential for drug interactions because other drugs may displace them from protein-binding sites, increasing the concentration of free (active) drug in the plasma, which can lead to toxicity. Example: Phenytoin (highly protein-bound) can be displaced by valproic acid, leading to increased free phenytoin levels and toxicity.",
      "correct_choice_id": 256984,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8211711700310846/8211711700310846.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/8211711700310846/8211711700310846.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89095,
      "choices": [
        {
          "id": 256988,
          "text": "They produce smooth and no fluctuating plasma concentration of the drug"
        },
        {
          "id": 256989,
          "text": "They minimize interindividual variations in the achieved plasma drug concentration"
        },
        {
          "id": 256990,
          "text": "They produce high peak plasma concentration of the drug"
        },
        {
          "id": 256991,
          "text": "They avoid hepatic first pass metabolism of the drug"
        }
      ],
      "text": "All of the following are advantages of transdermal drug delivery systems EXCEPT:",
      "unique_key": "Q6328487",
      "question_audio": null,
      "question_video": null,
      "map_id": 34561371,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) They produce high peak plasma concentration of the drug Transdermal drug delivery systems (TDDS) provide slow and sustained drug release through the skin, leading to a steady-state plasma concentration rather than a high peak concentration. Unlike oral or intravenous administration, which can cause rapid spikes in drug levels, transdermal systems ensure controlled absorption over time, minimizing fluctuations and reducing the risk of toxicity. For example, fentanyl patches, nicotine patches, and hormonal patches (e.g., estradiol) are designed to maintain consistent plasma drug levels rather than causing sudden peaks. Incorrect Options: (A) They produce smooth and no fluctuating plasma concentration of the drug – Incorrect Transdermal drug delivery provides a controlled, steady release, avoiding the rapid peaks and troughs seen with oral or intravenous administration. This reduces side effects and maintains therapeutic efficacy over extended periods. Example: Nitroglycerin patches for angina provide continuous vasodilation without sudden drops in blood pressure. (B) They minimize interindividual variations in the achieved plasma drug concentration – Incorrect Since drug absorption through the skin bypasses variations in gastric pH, enzyme activity, and first-pass metabolism, interindividual differences in drug levels are reduced compared to oral administration. Factors like genetic polymorphisms in liver enzymes do not significantly affect the drug’s plasma concentration in transdermal delivery. (D) They avoid hepatic first-pass metabolism of the drug – Incorrect Transdermal drugs bypass the liver’s first-pass metabolism, as they directly enter the systemic circulation through the skin’s capillaries. This increases bioavailability, making transdermal delivery especially useful for drugs with extensive hepatic metabolism, such as nitroglycerin, estradiol, and fentanyl.",
      "correct_choice_id": 256990,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7657611700310911/7657611700310911.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7657611700310911/7657611700310911.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89096,
      "choices": [
        {
          "id": 256992,
          "text": "Metabolism of the drug in liver"
        },
        {
          "id": 256993,
          "text": "Redistribution"
        },
        {
          "id": 256994,
          "text": "High plasma protein binding of the drug"
        },
        {
          "id": 256995,
          "text": "Excretion of drug by kidney"
        }
      ],
      "text": "A new drug is found to be highly lipid soluble, it is metabolized at a slower rate of 10% per hour. On intravenous injection it produces general anesthesia that lasts only for 15 min. This short duration of anesthesia is due to:",
      "unique_key": "Q4888616",
      "question_audio": null,
      "question_video": null,
      "map_id": 34810083,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Redistribution The short duration of anesthesia following intravenous injection of a highly lipid-soluble drug is primarily due to redistribution. When such a drug is administered, it rapidly reaches the highly perfused organs such as the brain, where it exerts its anesthetic effects. However, due to its high lipid solubility, the drug also quickly redistributes to other tissues with higher fat content (like muscle and adipose tissue), which act as reservoirs. This redistribution lowers the concentration of the drug in the brain, thus terminating its anesthetic effect even though the drug is still present in the body. This explains why the anesthesia only lasts around 15 minutes—it's not because the drug is eliminated, but because it's redistributed away from the site of action. Option A: Metabolism of the drug in liver Although metabolism plays a role in drug elimination, in this case, the drug is metabolized at a slow rate (10% per hour), which is too slow to account for the rapid termination of anesthesia. The short duration cannot be attributed to liver metabolism since the drug persists in the body for a longer time. Option C: High plasma protein binding of the drug High plasma protein binding would reduce the free drug available to cross the blood-brain barrier, potentially delaying or reducing its effect, but it wouldn’t explain the short duration of action once anesthesia has already been achieved. It does not contribute to the rapid offset of drug effect. Option D: Excretion of drug by kidney Renal excretion is also a relatively slow process compared to the rapid offset of anesthesia. Like metabolism, renal elimination cannot account for the very short (15-minute) duration of anesthetic action, especially in the case of a highly lipid-soluble compound that redistributes extensively.",
      "correct_choice_id": 256993,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52544131700310930/52544131700310930.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/52544131700310930/52544131700310930.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89097,
      "choices": [
        {
          "id": 256996,
          "text": "Conversion of lipid soluble drugs to water soluble metabolites"
        },
        {
          "id": 256997,
          "text": "Activation of the active drug"
        },
        {
          "id": 256998,
          "text": "Conversion of prodrug to active metabolite"
        },
        {
          "id": 256999,
          "text": "Conversion of water soluble drug to lipid soluble metabolites"
        }
      ],
      "text": "Metabolism of a drug primarily results in",
      "unique_key": "Q4293459",
      "question_audio": null,
      "question_video": null,
      "map_id": 34947362,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) After metabolism most of the drugs become inactive and are excreted through the kidney. Lipid soluble drugs will be reabsorbed whereas water soluble drugs are easily excreted. Thus, metabolism of drugs helps in the conversion of lipid soluble drugs to water soluble metabolites. Ref Katzung",
      "correct_choice_id": 256996,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21290571700311016/21290571700311016.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/21290571700311016/21290571700311016.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89098,
      "choices": [
        {
          "id": 257000,
          "text": "Low ionization at physiological pH values"
        },
        {
          "id": 257001,
          "text": "High lipid solubility"
        },
        {
          "id": 257002,
          "text": "High tissue binding"
        },
        {
          "id": 257003,
          "text": "High plasma protein binding"
        }
      ],
      "text": "All of the following factors tend to increase the volume of distribution of a drug EXCEPT",
      "unique_key": "Q9892737",
      "question_audio": null,
      "question_video": null,
      "map_id": 34897372,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) High plasma protein binding The volume of distribution (Vd) refers to the extent to which a drug is distributed throughout body tissues compared to the plasma. Drugs that are highly bound to plasma proteins remain in the bloodstream and have a lower Vd. When a drug is bound to albumin or other plasma proteins, it is not freely available to distribute into tissues, leading to a lower Vd. Thus, high plasma protein binding limits the distribution of the drug, decreasing its Vd. Incorrect Options: (A) Low ionization at physiological pH values – Incorrect Non-ionized (lipophilic) drugs cross cell membranes more easily than ionized (hydrophilic) drugs, leading to greater tissue distribution and increased Vd. Highly ionized drugs, on the other hand, remain in the plasma and have a lower Vd. (B) High lipid solubility – Incorrect Lipid-soluble drugs penetrate cell membranes easily and accumulate in tissues, particularly in fat stores, the brain, and other highly perfused organs. This increases distribution and results in a higher Vd. (C) High tissue binding – Incorrect Drugs that have a strong affinity for tissues (e.g., muscle, fat) accumulate in these compartments, leading to a larger Vd. Examples include lipophilic drugs like amiodarone, which has a very high Vd due to extensive tissue binding.",
      "correct_choice_id": 257003,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46868011700311031/46868011700311031.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46868011700311031/46868011700311031.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89099,
      "choices": [
        {
          "id": 257004,
          "text": "Morphine sulfate"
        },
        {
          "id": 257005,
          "text": "Hyoscine hydrobromide"
        },
        {
          "id": 257006,
          "text": "Quinine dihydrochloride"
        },
        {
          "id": 257007,
          "text": "Diclofenac sodium"
        }
      ],
      "text": "Which of the following drugs has maximum chances of absorption from gastric mucosa?",
      "unique_key": "Q3352719",
      "question_audio": null,
      "question_video": null,
      "map_id": 34397253,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Diclofenac sodium Diclofenac sodium is a weak acid (pKa ~4.0), which means it remains largely non-ionized in the acidic pH of the stomach (pH ~1-3). Non-ionized drugs are more lipophilic and can readily cross biological membranes via passive diffusion. This property allows diclofenac sodium to be efficiently absorbed from the gastric mucosa, making it the drug with the maximum chances of absorption among the given options. Incorrect Options: (A) Morphine sulfate – Incorrect Morphine sulfate is a weak base (pKa ~7.9). In the acidic environment of the stomach, it remains highly ionized, making it less lipid-soluble and poorly absorbed from the gastric mucosa. Instead, it is primarily absorbed in the alkaline pH of the intestines. (B) Hyoscine hydrobromide – Incorrect Hyoscine (also called scopolamine) is a quaternary ammonium compound, which means it remains highly ionized regardless of pH. This reduces its ability to cross the gastric mucosa, leading to poor absorption from the stomach. (C) Quinine dihydrochloride – Incorrect Quinine is a weak base (pKa ~8.4), so in the acidic stomach environment, it remains ionized, making its absorption from the gastric mucosa less efficient. Like morphine, it is better absorbed in the intestines, where the pH is more favorable for its non-ionized form.",
      "correct_choice_id": 257007,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28975061700311069/28975061700311069.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28975061700311069/28975061700311069.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89100,
      "choices": [
        {
          "id": 257008,
          "text": "Weak acids"
        },
        {
          "id": 257009,
          "text": "Strong bases"
        },
        {
          "id": 257010,
          "text": "Strong acids"
        },
        {
          "id": 257011,
          "text": "Weak bases"
        }
      ],
      "text": "Urinary alkalinizing agents are administered in case of poisoning due to drugs which are",
      "unique_key": "Q7738880",
      "question_audio": null,
      "question_video": null,
      "map_id": 34148397,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Weak acids Urinary alkalinization is used to enhance the elimination of weakly acidic drugs in cases of poisoning. Alkalinizing agents like sodium bicarbonate (NaHCO3) increase urine pH, which ionizes weak acids, making them more water-soluble and less likely to be reabsorbed in the renal tubules. This process, known as \"ion trapping,\" facilitates the excretion of weak acids in the urine. Examples of weak acidic drugs whose elimination can be enhanced by urinary alkalinization include aspirin (salicylates), phenobarbital, and methotrexate. Incorrect Options: (B) Strong bases – Incorrect Strong bases do not significantly undergo renal reabsorption or ion trapping. Their elimination is not enhanced by urinary alkalinization. Examples: Sodium hydroxide (NaOH) and potassium hydroxide (KOH), which are corrosive substances rather than drugs. (C) Strong acids – Incorrect Strong acids (like hydrochloric acid, sulfuric acid) are highly dissociated in body fluids and do not significantly respond to changes in urine pH. Their elimination is not affected by urinary alkalinization. (D) Weak bases – Incorrect Weak bases (such as amphetamines and quinidine) are better eliminated in acidic urine, not alkaline urine. Acidifying agents (e.g., ammonium chloride, ascorbic acid) are used instead to promote their excretion.",
      "correct_choice_id": 257008,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27901541700311081/27901541700311081.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/27901541700311081/27901541700311081.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89101,
      "choices": [
        {
          "id": 257012,
          "text": "Inhalational"
        },
        {
          "id": 257013,
          "text": "Sublingual"
        },
        {
          "id": 257014,
          "text": "Transdermal"
        },
        {
          "id": 257015,
          "text": "Subcutaneous"
        }
      ],
      "text": "Titration of the dose of a drug with the response can be done with which of the following routes of administration?",
      "unique_key": "Q7413911",
      "question_audio": null,
      "question_video": null,
      "map_id": 34495484,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Inhalational Titration of the dose of a drug with the response refers to adjusting the drug dose based on the immediate feedback of its effects. Inhalational administration is the most suitable route for this because it provides rapid onset of action and allows real-time monitoring of the drug's effects. Example: Inhaled bronchodilators (e.g., salbutamol, ipratropium) for asthma allow the patient or clinician to adjust the dose based on symptom relief. Inhalational anesthetics (e.g., sevoflurane, isoflurane) are also titrated precisely during surgery to achieve the desired depth of anesthesia. This route is particularly useful for drugs with a short onset and short duration of action, allowing for fine control over dosing. Incorrect Options: (B) Sublingual – Incorrect Sublingual administration (e.g., nitroglycerin for angina) provides rapid absorption but does not allow precise real-time titration as well as the inhalational route does. Once the drug is absorbed, it cannot be easily adjusted or withdrawn. (C) Transdermal – Incorrect Transdermal drug delivery provides slow and continuous drug release (e.g., fentanyl patches for pain, nicotine patches for smoking cessation). Since it does not provide an immediate response, it is not suitable for dose titration based on real-time effects. (D) Subcutaneous – Incorrect Subcutaneous injections (e.g., insulin, heparin) take time for absorption and do not allow immediate dose adjustments. The response is not as rapid as inhalational administration, making titration difficult.*",
      "correct_choice_id": 257012,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6334391700311092/6334391700311092.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/6334391700311092/6334391700311092.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89102,
      "choices": [
        {
          "id": 257016,
          "text": "Hepatic metabolism and renal excretion are the two most important mechanisms Drugstore"
        },
        {
          "id": 257017,
          "text": "Drugs must be excreted from the body to terminate their action"
        },
        {
          "id": 257018,
          "text": "Metabolism of drugs always abolishes their pharmacologic activity"
        },
        {
          "id": 257019,
          "text": "Distribution of a drug out of blood stream terminates the drug's effects"
        }
      ],
      "text": "Which of the following is true Regarding termination of drug action",
      "unique_key": "Q6857989",
      "question_audio": null,
      "question_video": null,
      "map_id": 34432306,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hepatic metabolism and renal excretion are the two most important mechanisms of drug termination The termination of drug action primarily occurs through hepatic metabolism and renal excretion, as these processes help eliminate the drug from the body or convert it into inactive metabolites. Hepatic Metabolism: The liver is the primary site of drug metabolism via phase I (oxidation, reduction, hydrolysis) and phase II (conjugation) reactions. These reactions convert lipid-soluble drugs into more water-soluble metabolites, facilitating their excretion. Renal Excretion: The kidneys filter drugs and metabolites from the bloodstream and eliminate them through urine. Glomerular filtration, tubular secretion, and tubular reabsorption play roles in determining how efficiently a drug is excreted. Together, these mechanisms reduce drug concentration in the plasma, leading to the termination of drug action. Incorrect Options: (B) Drugs must be excreted from the body to terminate their action – Incorrect Drug action does not always require complete excretion for termination. Redistribution of highly lipid-soluble drugs (e.g., thiopental) into fat tissues can terminate their effect without immediate excretion. Metabolism can also inactivate a drug before excretion. (C) Metabolism of drugs always abolishes their pharmacologic activity – Incorrect Metabolism does not always abolish activity. Some drugs are metabolized into active metabolites (e.g., codeine to morphine, prodrugs like enalapril to enalaprilat). First-pass metabolism can sometimes activate or enhance drug effects instead of terminating them. (D) Distribution of a drug out of the bloodstream terminates the drug’s effects – Incorrect Distribution out of the bloodstream does not always mean drug action is terminated. Many drugs act at their site of action inside tissues (e.g., intracellular receptors, CNS drugs, muscle relaxants) rather than in the bloodstream. While redistribution can terminate the effects of some drugs (e.g., thiopental for anesthesia), this is not a general rule for all drugs.",
      "correct_choice_id": 257016,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41179921700311104/41179921700311104.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41179921700311104/41179921700311104.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89103,
      "choices": [
        {
          "id": 257020,
          "text": "Orphan Drug"
        },
        {
          "id": 257021,
          "text": "Nocebo"
        },
        {
          "id": 257022,
          "text": "Psychotropic Drug"
        },
        {
          "id": 257023,
          "text": "Placebo"
        }
      ],
      "text": "Drug which works by psychodynamic rather than Pharmacodynamic means is",
      "unique_key": "Q7741029",
      "question_audio": null,
      "question_video": null,
      "map_id": 34071801,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Placebo A placebo is a substance or treatment that has no active pharmacological ingredient but produces effects due to psychological and physiological responses. It works by psychodynamic means, meaning its effects are based on the patient’s belief, expectation, and psychological conditioning rather than direct pharmacological action. The placebo effect occurs when a patient experiences perceived improvement in symptoms after taking an inert substance, such as a sugar pill or saline injection, simply because they believe they are receiving an active drug. Neurobiological mechanisms (e.g., dopamine release in Parkinson’s, endorphin activation in pain relief) contribute to the placebo response. Placebos are commonly used in clinical trials to compare new drugs against a non-active treatment. Incorrect Options: (A) Orphan Drug – Incorrect Orphan drugs are medications developed for rare diseases affecting a small population. They work through specific pharmacodynamic mechanisms to treat a particular condition, unlike placebos. (B) Nocebo – Incorrect A nocebo is the opposite of a placebo—it causes negative effects in patients who believe they are taking a harmful substance, even if the treatment is inert. The nocebo effect is psychological, but it does not refer to a drug that works by psychodynamic means like a placebo. (C) Psychotropic Drug – Incorrect Psychotropic drugs (e.g., antidepressants, antipsychotics, anxiolytics) have direct pharmacodynamic effects on neurotransmitters in the brain, such as serotonin, dopamine, and GABA. Unlike a placebo, they have active chemical properties that alter brain function.",
      "correct_choice_id": 257023,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44974821700311142/44974821700311142.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44974821700311142/44974821700311142.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89104,
      "choices": [
        {
          "id": 257024,
          "text": "Secondary Effect"
        },
        {
          "id": 257025,
          "text": "Toxic Effect"
        },
        {
          "id": 257026,
          "text": "Side Effect"
        },
        {
          "id": 257027,
          "text": "Adverse drug event"
        }
      ],
      "text": "All of the following are predicted from the pharmacological profile of a drug except",
      "unique_key": "Q6158762",
      "question_audio": null,
      "question_video": null,
      "map_id": 34492104,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Adverse Drug Event An adverse drug event (ADE) refers to any unexpected or unintended harm caused by a drug, which may or may not be related to its pharmacological profile. ADEs can result from medication errors, allergic reactions, or unexpected patient-specific responses, rather than the predicted actions of the drug. ADEs can occur due to incorrect dosing, drug interactions, or patient-specific factors (e.g., genetic variations, organ dysfunction), making them unpredictable based on the standard pharmacological profile. Unlike side effects or toxic effects, which are expected consequences of drug action, ADEs are not necessarily linked to the known mechanism of action. Example: Anaphylaxis with penicillin is an ADE because it is an unexpected immune-mediated reaction rather than a pharmacologically predicted response. Incorrect Options: (A) Secondary Effect – Incorrect A secondary effect is a predicted, but unintended consequence of drug action that occurs due to the drug’s pharmacology. Example: Antihistamines causing drowsiness—though used for allergies, they also block histamine in the brain, leading to sedation. Since secondary effects are expected from pharmacological knowledge, they can be predicted from the drug profile. (B) Toxic Effect – Incorrect Toxic effects occur when a drug exceeds its therapeutic range, leading to harmful outcomes. These are dose-dependent and predictable based on pharmacokinetics and pharmacodynamics. Example: Digoxin toxicity (arrhythmias, nausea) at high doses is a known pharmacological consequence. (C) Side Effect – Incorrect A side effect is an unintended but predictable response to a drug at therapeutic doses. These are dose-independent and related to the drug’s pharmacological action. Example: NSAIDs causing gastric irritation due to inhibition of protective prostaglandins.",
      "correct_choice_id": 257027,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35799371700311152/35799371700311152.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/35799371700311152/35799371700311152.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89105,
      "choices": [
        {
          "id": 257028,
          "text": "Insulin"
        },
        {
          "id": 257029,
          "text": "NO"
        },
        {
          "id": 257030,
          "text": "Herceptin"
        },
        {
          "id": 257031,
          "text": "Nesiritide"
        }
      ],
      "text": "Which of the following acts through membrane Soluble guanylyl cyclase",
      "unique_key": "Q2934947",
      "question_audio": null,
      "question_video": null,
      "map_id": 34071675,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Nitric Oxide (NO) Nitric oxide (NO) acts through soluble guanylyl cyclase, which is a cytoplasmic (not membrane-bound) enzyme. NO diffuses freely across cell membranes and activates soluble guanylyl cyclase (sGC) inside the cytoplasm. This leads to increased production of cyclic GMP (cGMP), which mediates smooth muscle relaxation, vasodilation, and other physiological effects. NO is a gasotransmitter that plays a critical role in vascular smooth muscle relaxation, neurotransmission, and immune responses. Example: Nitroglycerin and other nitrates release NO, leading to vasodilation via the cGMP pathway. Incorrect Options: (A) Insulin – Incorrect Insulin acts through a membrane-bound tyrosine kinase receptor, not guanylyl cyclase. Upon insulin binding, the receptor undergoes autophosphorylation, leading to activation of intracellular signaling cascades (PI3K/Akt and MAPK pathways) that regulate glucose uptake and metabolism. (C) Herceptin – Incorrect Herceptin (Trastuzumab) is a monoclonal antibody that targets HER2 (a receptor tyrosine kinase) on the cell membrane. It does not involve guanylyl cyclase but instead inhibits HER2-mediated signaling, which is crucial for cancer cell survival in HER2-positive breast cancer. (D) Nesiritide – Incorrect Nesiritide is a recombinant B-type natriuretic peptide (BNP) that binds to membrane-bound (particulate) guanylyl cyclase (pGC), not soluble guanylyl cyclase. This leads to an increase in cGMP production, causing vasodilation and natriuresis in heart failure patients.",
      "correct_choice_id": 257029,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70646311700311167/70646311700311167.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70646311700311167/70646311700311167.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89106,
      "choices": [
        {
          "id": 257032,
          "text": "First class metabolism reduces bioavailability"
        },
        {
          "id": 257033,
          "text": "Heparin not absorbed due to its large size"
        },
        {
          "id": 257034,
          "text": "Drugs which dissolve in water are rapidly absorbed from GIT"
        },
        {
          "id": 257035,
          "text": "Highly ionized molecule are absorbed from stomach"
        }
      ],
      "text": "Choose the incorrect statement regarding drug absorption",
      "unique_key": "Q5281228",
      "question_audio": null,
      "question_video": null,
      "map_id": 34091919,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Highly ionized molecules are absorbed from the stomach – Incorrect Highly ionized molecules are not well absorbed from the stomach because they cannot easily cross the lipophilic cell membranes of the gastric mucosa. Drug absorption largely depends on the pH partition hypothesis, which states that non-ionized (lipophilic) forms of a drug are more easily absorbed than ionized (hydrophilic) forms. The stomach has an acidic environment (pH ~1-3), meaning weak acids (e.g., aspirin) remain largely non-ionized and get absorbed efficiently. Weak bases, on the other hand, become highly ionized in this acidic pH and are poorly absorbed. Since highly ionized molecules are not absorbed efficiently from the stomach, option (D) is incorrect. Incorrect Options Explained: (A) First-pass metabolism reduces bioavailability – Correct First-pass metabolism occurs when a drug is metabolized in the liver or intestinal wall before reaching systemic circulation. This reduces the bioavailability of orally administered drugs, meaning less active drug reaches the bloodstream. Example: Propranolol, Nitroglycerin undergo extensive first-pass metabolism. (B) Heparin is not absorbed due to its large size – Correct Heparin is a large, highly charged polysaccharide that cannot be absorbed through the gastrointestinal tract. It is always administered parenterally (IV or SC) because oral administration is ineffective. (C) Drugs that dissolve in water are rapidly absorbed from the GIT – Correct Water-soluble drugs dissolve quickly in gastrointestinal fluids, facilitating faster absorption if they can also cross cell membranes. However, drugs must have a balance of water solubility (for dissolution) and lipid solubility (for membrane permeability) for optimal absorption.",
      "correct_choice_id": 257035,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/12263351700311207/12263351700311207.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/12263351700311207/12263351700311207.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89107,
      "choices": [
        {
          "id": 257036,
          "text": "Absorption"
        },
        {
          "id": 257037,
          "text": "Distribution"
        },
        {
          "id": 257038,
          "text": "Elimination"
        },
        {
          "id": 257039,
          "text": "Glycosylation"
        }
      ],
      "text": "A 28-year-old man with seborrheic dermatitis is prescribed a topical corticosteroid creme by his dermatologist in hopes of alleviating the chronic rash and erythema on the cheeks. Which of the following steps is most critical to achieve a therapeutic drug concentration in plasma?",
      "unique_key": "Q4247467",
      "question_audio": null,
      "question_video": null,
      "map_id": 34088692,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Absorption Explanation for the Correct Answer: Absorption is the most critical step in achieving a therapeutic drug concentration in plasma when using topical corticosteroids. Since the medication is applied to the skin rather than being administered systemically (e.g., orally or intravenously), it must penetrate the stratum corneum and reach the underlying tissues to exert its effect. Factors affecting absorption include: Skin thickness: Absorption is greater in areas with thin skin (e.g., face, genitals) and lower in areas with thick skin (e.g., palms, soles). Hydration of the skin: Moisturizing the skin enhances drug penetration. Inflammation: Inflamed or damaged skin has increased permeability, leading to higher drug absorption. Vehicle and formulation: Ointments tend to provide better penetration compared to creams or lotions. Since corticosteroids act locally but can still be absorbed into systemic circulation, absorption is the most crucial factor in determining therapeutic and potential systemic effects. Explanation for the Incorrect Answers: (B) Distribution Distribution refers to the movement of the drug from the bloodstream to tissues and organs. In the case of topical corticosteroids, the primary action is local, and systemic distribution is not a major concern unless absorption is excessive. While systemic corticosteroids require proper distribution to reach target tissues, topical therapy depends primarily on absorption through the skin. (C) Elimination Elimination (metabolism and excretion) occurs after the drug has already been absorbed and distributed. Corticosteroids are metabolized primarily in the liver and excreted by the kidneys, but this occurs after absorption has taken place. Since the main challenge with topical corticosteroids is ensuring proper skin penetration, elimination is not the most critical step for achieving a therapeutic effect. (D) Glycosylation Glycosylation is a post-translational modification of proteins, not a key factor in drug pharmacokinetics. Corticosteroids do not undergo glycosylation as a major metabolic process. This option is not relevant to the question.",
      "correct_choice_id": 257036,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28277751700306088/28277751700306088.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28277751700306088/28277751700306088.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89108,
      "choices": [
        {
          "id": 257040,
          "text": "Analgesics, oral route"
        },
        {
          "id": 257041,
          "text": "Analgesics, transdermal route"
        },
        {
          "id": 257042,
          "text": "Phenoxybenzamine, intravenous route"
        },
        {
          "id": 257043,
          "text": "Phentolamine, intravenous route"
        }
      ],
      "text": "A 52-year-old woman with multiple endocrine neoplasia syndromes has a large pancreatic tumor and bilateral adrenal tumors. She is hospitalized on the medicine service. The tumor is considered inoperable. Her blood pressure is 180/100 mm Hg. In addition to intravenous fluids, this patient may benefit from which of the following interventions?",
      "unique_key": "Q1349854",
      "question_audio": null,
      "question_video": null,
      "map_id": 34071928,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Phenoxybenzamine, Intravenous Route Explanation for the Correct Answer: The patient has multiple endocrine neoplasia (MEN) syndrome, and the combination of a large pancreatic tumor and bilateral adrenal tumors strongly suggests MEN type 2 with a pheochromocytoma. Pheochromocytomas cause hypertension due to excessive catecholamine secretion (epinephrine, norepinephrine, and dopamine). Phenoxybenzamine is an irreversible, non-selective alpha-blocker that provides long-acting alpha-adrenergic blockade. It is the first-line treatment for pheochromocytoma-induced hypertension because it prevents catecholamine-induced vasoconstriction. Since the patient is hospitalized and has severe hypertension (180/100 mmHg), intravenous phenoxybenzamine is the most effective way to stabilize blood pressure quickly. It also prevents hypertensive crises that can be triggered by stress, surgery, or certain drugs. Thus, option (C) is correct because phenoxybenzamine is the preferred agent for preoperative and symptomatic treatment of pheochromocytoma-induced hypertension. Explanation for the Incorrect Answers: (A) Analgesics, Oral Route While pain control may be necessary, oral analgesics do not directly address the hypertensive crisis. The primary concern is uncontrolled blood pressure due to catecholamine excess, which requires alpha-adrenergic blockade. Thus, analgesics alone would not be the best immediate intervention. (B) Analgesics, Transdermal Route Similar to oral analgesics, transdermal analgesics (e.g., fentanyl patches) do not treat hypertension and would not address the life-threatening effects of pheochromocytoma. Additionally, transdermal analgesics take time to reach effective plasma levels, making them inappropriate for immediate management. Therefore, they are not the best choice. (D) Phentolamine, Intravenous Route Phentolamine is a reversible alpha-blocker that can be used for acute hypertensive crises in pheochromocytoma, but it is short-acting and requires frequent dosing. While it can be used in emergencies, phenoxybenzamine is preferred for long-term management because of its irreversible blockade and sustained effect. Phentolamine is useful for acute hypertensive episodes but is not the first-line choice for continuous management.",
      "correct_choice_id": 257042,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28671701700306150/28671701700306150.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/28671701700306150/28671701700306150.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89109,
      "choices": [
        {
          "id": 257044,
          "text": "= 0.7 × Vd/t1/2"
        },
        {
          "id": 257045,
          "text": "= amount of drug in body/drug plasma concentration"
        },
        {
          "id": 257046,
          "text": "= Cp × CL/F"
        },
        {
          "id": 257047,
          "text": "= Cp × Vd/F"
        }
      ],
      "text": "A 62-year-old man is recovering in the hospital following a heart attack. He is started on clopidogrel. The initial dose, also known as the loading dose, is higher than his normal daily dose, also known as the maintenance dose. Which of the following represents the calculation for a maintenance dose?",
      "unique_key": "Q4172075",
      "question_audio": null,
      "question_video": null,
      "map_id": 34986120,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Maintenance Dose = Cp × CL / F Explanation for the Correct Answer: The maintenance dose is the dose required to maintain a steady plasma drug concentration (Cp) over time. The correct formula for calculating the maintenance dose is: Maintenance dose= (Cp×CL)/F Where: Cp = Target plasma concentration of the drug CL = Clearance of the drug from the body F = Bioavailability (fraction of drug absorbed into circulation; F = 1 for IV drugs, but <1 for oral drugs like clopidogrel) In this case, clopidogrel is an oral antiplatelet agent with a variable bioavailability, so the maintenance dose must account for clearance (CL) and bioavailability (F) to ensure effective plasma levels. Incorrect Answers: (A) = 0.7 × Vd / t1/2 Incorrect, because this formula is used to calculate the elimination rate constant (k), not the maintenance dose. The correct relationship is: K=0.7/(t1/2) This helps determine drug elimination over time, but it does not directly determine the maintenance dose. (B) = Amount of drug in body / Drug plasma concentration Incorrect, because this formula calculates the volume of distribution (Vd), not the maintenance dose. The formula for Vd is: Vd=Amount of drug in body/(Plasma concentration (CP)) This helps determine drug distribution, but it does not predict the required dose. (D) = Cp × Vd / F Incorrect, because this is the formula for the loading dose, not the maintenance dose. The loading dose is used to rapidly achieve a therapeutic plasma concentration, whereas the maintenance dose ensures steady-state levels.",
      "correct_choice_id": 257046,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65336221700304918/65336221700304918.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/65336221700304918/65336221700304918.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89110,
      "choices": [
        {
          "id": 257048,
          "text": "Cardiogenic shock"
        },
        {
          "id": 257049,
          "text": "Cirrhosis"
        },
        {
          "id": 257050,
          "text": "Heart failure"
        },
        {
          "id": 257051,
          "text": "Hypermetabolic state"
        }
      ],
      "text": "A 30 -year-old man is hospitalized after a fall from the ladder. His current medical problems include cardiogenic shock, heart failure, renal disease, and cirrhosis from chronic alcoholism. Because of weight loss, he is felt to be somewhat hypermetabolic. Which of the following factors will have the most significant effect to decrease drug half-life of medications administered to him?",
      "unique_key": "Q8060214",
      "question_audio": null,
      "question_video": null,
      "map_id": 34716317,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hypermetabolic State Explanation for the Correct Answer: A hypermetabolic state (such as seen in severe illness, trauma, or chronic weight loss) leads to increased metabolic activity, particularly in the liver. This results in: Increased drug metabolism (especially Phase I metabolism by cytochrome P450 enzymes). Increased drug clearance, leading to a decreased drug half-life. Higher hepatic enzyme activity, accelerating drug breakdown and elimination. Since drug half-life is inversely proportional to clearance (CL), an increased metabolic rate leads to faster drug elimination and a shorter half-life. Thus, among the given choices, the hypermetabolic state has the most significant effect in decreasing drug half-life. Explanation for the Incorrect Answers: (A) Cardiogenic Shock: Incorrect, because cardiogenic shock leads to decreased cardiac output, which reduces drug delivery to the liver and kidneys. This slows down drug clearance, leading to a longer half-life rather than a shorter one. (B) Cirrhosis: Incorrect, because liver disease impairs drug metabolism, especially drugs undergoing hepatic clearance. In cirrhosis, reduced liver enzyme function leads to delayed drug clearance, increasing the drug’s half-life rather than shortening it. (C) Heart Failure: Incorrect, because heart failure leads to poor perfusion of the liver and kidneys, reducing drug metabolism and clearance. This results in prolonged drug half-life, not a decreased one.",
      "correct_choice_id": 257051,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59605661700304945/59605661700304945.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59605661700304945/59605661700304945.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89111,
      "choices": [
        {
          "id": 257052,
          "text": "Atropine should be injected"
        },
        {
          "id": 257053,
          "text": "Dopamine should be injected"
        },
        {
          "id": 257054,
          "text": "Nothing"
        },
        {
          "id": 257055,
          "text": "Phentolamine should be injected"
        }
      ],
      "text": "You are an intern posted in medicine ICU. A 40 -year-old man is in the intensive care unit with sepsis. He is receiving intravenous (IV) vasopressors to maintain his blood pressure. During morning rounds the consultant notices his IV has extravasated and the skin around the IV site is cool and pale. He question you about the appropriate management, your answer would be ?",
      "unique_key": "Q2101416",
      "question_audio": null,
      "question_video": null,
      "map_id": 34478430,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Phentolamine Should Be Injected Explanation for the Correct Answer: The patient is experiencing extravasation of vasopressors, leading to local ischemia and tissue necrosis. Vasopressors such as dopamine, norepinephrine, and epinephrine cause vasoconstriction, which can result in skin pallor, coolness, and potential necrosis at the site of extravasation. Phentolamine, a non-selective alpha-adrenergic antagonist, reverses vasoconstriction, improves local blood flow, and prevents tissue necrosis. It should be injected subcutaneously around the affected area as soon as possible. This action counteracts vasopressor-induced ischemia, minimizing the risk of skin necrosis and ulceration. Thus, phentolamine is the treatment of choice for vasopressor extravasation. Explanation for the Incorrect Answers: (A) Atropine Should Be Injected Atropine is a muscarinic antagonist that increases heart rate and has no role in treating vasopressor extravasation. It does not reverse vasoconstriction and will not improve blood flow to the affected area. (B) Dopamine Should Be Injected Dopamine itself is a vasopressor and can worsen vasoconstriction if injected. It would exacerbate the ischemia, leading to more severe tissue damage. (C) Nothing If left untreated, vasopressor extravasation can lead to skin necrosis, ulceration, and permanent tissue damage. Immediate intervention is required, and doing nothing is not an acceptable management approach.",
      "correct_choice_id": 257055,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46425041700304962/46425041700304962.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46425041700304962/46425041700304962.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89112,
      "choices": [
        {
          "id": 257056,
          "text": "Decreases Km"
        },
        {
          "id": 257057,
          "text": "Decreases Vmax"
        },
        {
          "id": 257058,
          "text": "Increases Km"
        },
        {
          "id": 257059,
          "text": "Increases Vmax"
        }
      ],
      "text": "A 68-year-old man presents to the hospital with the complaint of difficulty urinating. He has difficulty starting his stream and feels his bladder is still full after he urinates. He has to get up about four times a night to urinate. The physician starts him on finasteride, which noncompetitively inhibits 5a-reductase. What effect does a noncompetitive inhibitor have on enzyme kinetics?",
      "unique_key": "Q9699461",
      "question_audio": null,
      "question_video": null,
      "map_id": 34060684,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Decreases Vmax Explanation for the Correct Answer: Finasteride is a noncompetitive inhibitor of 5alpha-reductase, an enzyme that converts testosterone to dihydrotestosterone (DHT). Noncompetitive inhibition affects enzyme kinetics in the following way: Vmax (maximum reaction velocity) is decreased because the inhibitor binds to an allosteric site, not the active site, preventing the enzyme from functioning even if the substrate concentration is increased. Km (substrate concentration at half Vmax) remains unchanged because the substrate can still bind to the active site, but enzyme activity is reduced due to inhibition. Since noncompetitive inhibition decreases the total number of active enzyme molecules available, the overall reaction rate (Vmax) is lowered. Explanation for the Incorrect Answers: (A) Decreases Km Km represents the substrate affinity for the enzyme. Noncompetitive inhibitors do not affect substrate binding at the active site, so Km remains the same. A competitive inhibitor (not noncompetitive) would increase Km by competing with the substrate for the active site. (C) Increases Km As mentioned, Km remains unchanged in noncompetitive inhibition. If the inhibitor was competitive, it would increase Km by reducing substrate binding efficiency. (D) Increases Vmax Noncompetitive inhibition does not enhance enzyme activity; rather, it reduces the number of functional enzymes. Therefore, Vmax is decreased, not increased.",
      "correct_choice_id": 257057,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63821881700304982/63821881700304982.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63821881700304982/63821881700304982.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89113,
      "choices": [
        {
          "id": 257060,
          "text": "Drug A has a lower EC50"
        },
        {
          "id": 257061,
          "text": "Drug B has a lower EC50"
        },
        {
          "id": 257062,
          "text": "Drug A is less potent than Drug B"
        },
        {
          "id": 257063,
          "text": "Drug B should be given intramuscularly"
        }
      ],
      "text": "Two drugs are shown in the following figure. Both are antibiotics used to treat bacterial pneumonia. Which of the following statements is correct about the figure shown next?<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/Pharma-14.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4439098",
      "question_audio": null,
      "question_video": null,
      "map_id": 34373076,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Drug A has a lower EC50 Explanation for the Correct Answer: EC50 (half-maximal effective concentration) is the concentration of a drug required to achieve 50% of its maximum effect. A lower EC50 means higher potency, as a smaller concentration is needed to produce the desired effect. From the figure (which is not provided but assumed to show dose-response curves): Drug A reaches 50% of its maximum effect at a lower concentration than Drug B. This indicates that Drug A has a lower EC50, meaning it is more potent than Drug B. Thus, the correct answer is (A) Drug A has a lower EC50. Explanation for the Incorrect Answers: (B) Drug B has a lower EC50 – Incorrect The question states that Drug A has a lower EC50, meaning it reaches its half-maximal effect at a lower concentration than Drug B. If Drug B had a lower EC50, it would have been more potent, which contradicts the figure. (C) Drug A is less potent than Drug B – Incorrect Potency is inversely related to EC50: Lower EC50 = Higher potency Higher EC50 = Lower potency Since Drug A has a lower EC50 than Drug B, it is actually more potent, not less. (D) Drug B should be given intramuscularly – Incorrect The mode of administration (oral, intravenous, intramuscular, etc.) is not determined by EC50. Intramuscular administration depends on factors like drug stability, absorption rate, and bioavailability, not just potency. The question provides no indication that Drug B requires intramuscular administration.",
      "correct_choice_id": 257060,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62369131700304997/62369131700304997.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62369131700304997/62369131700304997.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89114,
      "choices": [
        {
          "id": 257064,
          "text": "Decrease efficacy of proteins they bind to"
        },
        {
          "id": 257065,
          "text": "Decrease potency of proteins they bind to"
        },
        {
          "id": 257066,
          "text": "For enzymes, Km is unchanged"
        },
        {
          "id": 257067,
          "text": "Cannot be overcomed by high concentrations of the protein’s native ligand or substrate"
        }
      ],
      "text": "A 49 -year-old farmer presents to the emergency department complaining of blurry vision, vomiting, and excessive sweating after splashing himself with carbamate insecticide while in farm. His condition improves after administration of atropine. Which of the following is true of competitive antagonists?",
      "unique_key": "Q1092257",
      "question_audio": null,
      "question_video": null,
      "map_id": 34725381,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Decrease potency of proteins they bind to Explanation for the Correct Answer: Atropine is a competitive antagonist of muscarinic acetylcholine receptors. In cases of carbamate insecticide poisoning, excessive acetylcholine accumulates due to the inhibition of acetylcholinesterase. This leads to cholinergic toxicity with symptoms such as blurred vision, vomiting, excessive sweating, salivation, diarrhea, and bradycardia. Atropine competitively binds to muscarinic receptors, preventing acetylcholine from exerting its effects, thereby reversing the muscarinic symptoms of poisoning. Competitive antagonists reduce the potency of the agonist (acetylcholine in this case) by increasing the concentration required to achieve the same effect, without affecting the maximum response (efficacy). Since higher concentrations of the native ligand (acetylcholine) can overcome the effects of a competitive antagonist, the potency decreases while the efficacy remains the same. Thus, the correct answer is (B) Decrease potency of proteins they bind to. Explanation for the Incorrect Answers: (A) Decrease efficacy of proteins they bind to – Incorrect Competitive antagonists do not reduce the maximal efficacy of the agonist. They shift the dose-response curve to the right (requiring a higher concentration of agonist to achieve the same effect), but the maximum effect remains unchanged. Noncompetitive antagonists reduce efficacy, not competitive antagonists. (C) For enzymes, Km is unchanged – Incorrect Competitive inhibition increases Km (the substrate concentration required to reach half-maximal velocity), because a higher substrate concentration is needed to achieve the same reaction speed. In contrast, noncompetitive inhibitors do not change Km but decrease Vmax. Since atropine is a competitive antagonist, it increases Km, making this answer incorrect. (D) Cannot be overcome by high concentrations of the protein’s native ligand or substrate – Incorrect Competitive antagonists can be overcome by increasing the concentration of the agonist (such as acetylcholine in this case). This is the key characteristic that differentiates competitive from noncompetitive antagonists, as noncompetitive antagonists cannot be overcome by increasing agonist concentration. Since atropine is a competitive antagonist, its effects can be reversed with higher levels of acetylcholine, making this answer incorrect.",
      "correct_choice_id": 257065,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42403401700305070/42403401700305070.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42403401700305070/42403401700305070.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89115,
      "choices": [
        {
          "id": 257068,
          "text": "Oral"
        },
        {
          "id": 257069,
          "text": "Intravenous"
        },
        {
          "id": 257070,
          "text": "Subcutaneous"
        },
        {
          "id": 257071,
          "text": "Rectal"
        }
      ],
      "text": "Which of the following routes of administration is most suitable for drugs that are not well absorbed from the gastrointestinal tract?",
      "unique_key": "Q1276297",
      "question_audio": null,
      "question_video": null,
      "map_id": 34914054,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Intravenous – Correct The intravenous (IV) route is the most suitable option for drugs that are not well absorbed from the gastrointestinal (GI) tract. IV administration bypasses the GI tract entirely, ensuring that the drug is delivered directly into the bloodstream. This results in 100% bioavailability, meaning the entire dose of the drug reaches systemic circulation without being lost due to poor absorption, degradation, or first-pass metabolism. It is particularly useful for poorly absorbed drugs, protein-based drugs (e.g., insulin, monoclonal antibodies), and drugs with rapid onset requirements (e.g., emergency medications like epinephrine and antibiotics like vancomycin). Thus, IV administration is the best route for drugs with poor GI absorption, making (B) the correct choice. Incorrect Options Explained: (A) Oral – Incorrect Drugs that are poorly absorbed from the GI tract would not be effective if taken orally. Many drugs undergo degradation in the stomach (due to gastric acid or enzymes) or suffer from poor intestinal permeability, leading to reduced bioavailability. Examples of poorly absorbed drugs via oral route: insulin, certain peptides, and biologics. Therefore, the oral route is not suitable for such drugs, making this option incorrect. (C) Subcutaneous – Incorrect Subcutaneous (SC) injections allow for slow and sustained absorption, but they still depend on tissue perfusion for drug uptake into the bloodstream. While SC is a good alternative for some drugs that are poorly absorbed orally (e.g., insulin), it does not guarantee rapid or complete bioavailability like IV administration. This makes SC a less optimal choice compared to IV for drugs that require immediate or complete absorption. (D) Rectal – Incorrect The rectal route bypasses part of the first-pass metabolism, but it still relies on mucosal absorption, which can be unpredictable. Many drugs are not well absorbed rectally or may cause irritation. It is mostly used for local effects (e.g., suppositories for hemorrhoids) or when oral administration is not possible (e.g., vomiting patients). However, for drugs that are systemically poorly absorbed via the GI tract, IV remains the superior option.",
      "correct_choice_id": 257069,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24242711727531739/24242711727531739.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24242711727531739/24242711727531739.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89116,
      "choices": [
        {
          "id": 257072,
          "text": "The fraction of an administered dose of a drug that reaches the systemic circulation"
        },
        {
          "id": 257073,
          "text": "The degree to which a drug binds to plasma proteins"
        },
        {
          "id": 257074,
          "text": "The rate at which a drug is metabolized by the liver"
        },
        {
          "id": 257075,
          "text": "The speed at which a drug is excreted from the body"
        }
      ],
      "text": "What does the term 'bioavailability' refer to?",
      "unique_key": "Q4805314",
      "question_audio": null,
      "question_video": null,
      "map_id": 34569380,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) The fraction of an administered dose of a drug that reaches the systemic circulation Bioavailability refers to the proportion of a drug that enters the bloodstream in its active form after administration. It is expressed as a percentage (%) and represents how much of the drug is available to produce a therapeutic effect. For intravenous (IV) administration, bioavailability is 100% because the drug is directly introduced into systemic circulation without any barriers. For oral administration, bioavailability can be lower due to incomplete absorption, degradation in the gastrointestinal (GI) tract, and first-pass metabolism in the liver. Factors affecting bioavailability include: drug solubility, formulation, first-pass metabolism, and gastric pH. Thus, bioavailability is best defined as the fraction of an administered dose that reaches systemic circulation, making (A) the correct answer. Incorrect Options Explained: (B) The degree to which a drug binds to plasma proteins – Incorrect Plasma protein binding refers to the extent a drug binds to albumin or other proteins in the blood. While this affects distribution and elimination, it is not the same as bioavailability, which focuses on the proportion of the drug that enters systemic circulation. Highly protein-bound drugs (e.g., warfarin) may have lower free drug concentrations, but this is unrelated to bioavailability. (C) The rate at which a drug is metabolized by the liver – Incorrect Hepatic metabolism affects drug clearance and elimination, but it does not define bioavailability. First-pass metabolism can reduce oral drug bioavailability (e.g., propranolol, nitroglycerin), but metabolism itself is not equivalent to bioavailability. Example: A drug may be rapidly metabolized, but if 90% of the dose reaches systemic circulation before metabolism, it still has high bioavailability. (D) The speed at which a drug is excreted from the body – Incorrect Drug excretion refers to the elimination of the drug from the body via the kidneys (urine), liver (bile), or lungs (exhalation). Excretion is a process that influences drug clearance but is not a measure of bioavailability. Example: A drug may have high bioavailability but be rapidly excreted, leading to a short duration of action.",
      "correct_choice_id": 257072,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44174831727531754/44174831727531754.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44174831727531754/44174831727531754.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89117,
      "choices": [
        {
          "id": 257076,
          "text": "Antihypertensives with antacids"
        },
        {
          "id": 257077,
          "text": "Anticoagulants with NSAIDs"
        },
        {
          "id": 257078,
          "text": "Antibiotics with oral contraceptives"
        },
        {
          "id": 257079,
          "text": "Antidiabetics with diuretics"
        }
      ],
      "text": "Which of the following interactions could potentially lead to an increased risk of bleeding?",
      "unique_key": "Q6432889",
      "question_audio": null,
      "question_video": null,
      "map_id": 34348202,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Anticoagulants with NSAIDs. Anticoagulants, such as warfarin, heparin, or direct oral anticoagulants (DOACs), work by inhibiting clot formation to prevent conditions like deep vein thrombosis (DVT) and stroke. NSAIDs (nonsteroidal anti-inflammatory drugs), such as ibuprofen and aspirin, inhibit cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis, which plays a role in platelet aggregation. NSAIDs, particularly aspirin, have antiplatelet effects that can further impair clotting mechanisms, increasing the risk of gastrointestinal (GI) bleeding, intracranial hemorrhage, and excessive bleeding from minor injuries. This interaction is especially dangerous in elderly individuals or those with predisposing conditions like peptic ulcer disease. The combined use of NSAIDs and anticoagulants should be closely monitored, and alternatives like acetaminophen (paracetamol) may be preferred for pain management in patients requiring anticoagulation therapy. Explanation of Incorrect Options: (A) Antihypertensives with antacids – This combination does not directly increase the risk of bleeding. Antacids, such as aluminum hydroxide or calcium carbonate, can reduce the absorption of certain antihypertensive medications like beta-blockers or ACE inhibitors, potentially leading to reduced effectiveness in controlling blood pressure, but this interaction is unrelated to bleeding risk. (C) Antibiotics with oral contraceptives – Some antibiotics, particularly rifampin and rifabutin, may reduce the effectiveness of oral contraceptives by inducing liver enzymes that enhance the metabolism of estrogen and progestin. However, this interaction does not directly contribute to an increased risk of bleeding. Other antibiotics, like broad-spectrum ones, may alter gut flora, potentially affecting estrogen reabsorption, but the impact on bleeding risk is minimal. (D) Antidiabetics with diuretics – This interaction is more relevant to blood glucose control rather than bleeding risk. Certain diuretics, especially thiazide and loop diuretics, can increase blood sugar levels, leading to poor glycemic control in diabetic patients. Conversely, some antidiabetic medications, such as sulfonylureas, may increase the risk of hypoglycemia when combined with diuretics, but this does not contribute to an increased risk of bleeding.",
      "correct_choice_id": 257077,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71785271727531769/71785271727531769.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71785271727531769/71785271727531769.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89118,
      "choices": [
        {
          "id": 257080,
          "text": "Increase absorption"
        },
        {
          "id": 257081,
          "text": "Decrease absorption"
        },
        {
          "id": 257082,
          "text": "No effect"
        },
        {
          "id": 257083,
          "text": "Alter the medication's metabolism"
        }
      ],
      "text": "What effect might a high-fat meal have on the absorption of certain oral medications?",
      "unique_key": "Q4732223",
      "question_audio": null,
      "question_video": null,
      "map_id": 34822581,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Increase absorption. A high-fat meal can enhance the absorption of certain oral medications, particularly lipophilic (fat-soluble) drugs. These drugs dissolve better in the presence of dietary fats, improving their solubility and facilitating their transport across the gastrointestinal (GI) mucosa. Additionally, high-fat meals can stimulate bile acid secretion, which aids in the emulsification and absorption of lipophilic drugs. Some medications classified as Biopharmaceutics Classification System (BCS) Class II drugs—which have low solubility but high permeability—benefit significantly from this effect. Examples include griseofulvin, certain HIV protease inhibitors (e.g., ritonavir), and some fat-soluble vitamins (A, D, E, K). The presence of food can also delay gastric emptying, which may prolong the drug's time in the stomach but enhance overall absorption in the intestine. Explanation of Incorrect Options: (B) Decrease absorption – While some drugs experience reduced absorption with food (especially hydrophilic drugs or those requiring an acidic environment), this is not a universal effect. For lipophilic drugs, a high-fat meal increases absorption rather than decreasing it. However, certain medications like tetracyclines, fluoroquinolones, and bisphosphonates may bind to food components (e.g., calcium or iron), leading to reduced bioavailability. (C) No effect – The presence of a high-fat meal does influence drug absorption for many medications. While some drugs may remain unaffected by food intake, particularly those with high water solubility and rapid dissolution (BCS Class I drugs like paracetamol or metoprolol), this is not the case for all medications. Since food—especially high-fat content—has demonstrable effects on drug absorption, this option is incorrect. (D) Alter the medication's metabolism – While food can sometimes impact drug metabolism by affecting liver enzyme activity, a high-fat meal primarily influences absorption rather than metabolism. Metabolic changes usually result from interactions involving the cytochrome P450 enzyme system, rather than the presence of dietary fat alone. Some drugs may have altered metabolism due to repeated exposure to high-fat diets, but this is not the primary effect seen immediately after a single high-fat meal.",
      "correct_choice_id": 257080,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25594891727531787/25594891727531787.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25594891727531787/25594891727531787.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89119,
      "choices": [
        {
          "id": 257084,
          "text": "Drug absorption through the skin"
        },
        {
          "id": 257085,
          "text": "Metabolism of oral drugs by the liver before reaching systemic circulation"
        },
        {
          "id": 257086,
          "text": "Excretion of drugs by the kidneys"
        },
        {
          "id": 257087,
          "text": "Distribution of drugs in body tissues"
        }
      ],
      "text": "Which of the following is an example of a first-pass effect?",
      "unique_key": "Q8594718",
      "question_audio": null,
      "question_video": null,
      "map_id": 34207619,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Metabolism of oral drugs by the liver before reaching systemic circulation. This is known as the first-pass effect (or first-pass metabolism). When a drug is taken orally, it is absorbed from the gastrointestinal (GI) tract and transported via the portal vein to the liver, where it undergoes significant metabolism before entering the systemic circulation. This can lead to a reduction in the bioavailability of the drug, meaning that a smaller amount of the active drug reaches the bloodstream to exert its therapeutic effect. Some drugs, like propranolol, nitroglycerin, and morphine, undergo extensive first-pass metabolism, which is why alternative routes of administration (such as sublingual, transdermal, or intravenous) may be used to bypass this effect. Explanation of Incorrect Options: (A) Drug absorption through the skin This is incorrect because drug absorption through the skin (transdermal administration) bypasses the first-pass effect entirely. Drugs applied to the skin are absorbed directly into the systemic circulation without passing through the liver first, avoiding hepatic metabolism before distribution. (C) Excretion of drugs by the kidneys This option refers to the elimination of drugs from the body, primarily through urine. While renal excretion plays a crucial role in drug clearance, it is not related to the first-pass metabolism, which occurs before the drug reaches systemic circulation. (D) Distribution of drugs in body tissues Drug distribution refers to the movement of a drug from the bloodstream into tissues and organs where it exerts its effects. This process occurs after the drug has already entered systemic circulation and is not a component of the first-pass effect, which occurs before the drug reaches circulation.",
      "correct_choice_id": 257085,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49423251727531932/49423251727531932.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49423251727531932/49423251727531932.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89120,
      "choices": [
        {
          "id": 257088,
          "text": "Route of administration"
        },
        {
          "id": 257089,
          "text": "Drug formulation"
        },
        {
          "id": 257090,
          "text": "Patient's age"
        },
        {
          "id": 257091,
          "text": "Receptor affinity"
        }
      ],
      "text": "Which of the following factors does NOT affect the bioavailability of a drug?",
      "unique_key": "Q9984771",
      "question_audio": null,
      "question_video": null,
      "map_id": 34198747,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Receptor affinity. Bioavailability refers to the fraction of an administered drug that reaches systemic circulation in an active form. It is influenced by factors such as absorption, first-pass metabolism, and drug formulation. However, receptor affinity does not affect bioavailability because it relates to pharmacodynamics, which describes how a drug interacts with its target receptor to produce an effect. Receptor affinity determines the strength of the drug’s action after it has entered circulation, not how much of the drug becomes available in the bloodstream. Explanation of Incorrect Options: (A) Route of administration This is incorrect because the route of administration significantly affects bioavailability. Intravenous (IV) administration provides 100% bioavailability since the drug directly enters the bloodstream. In contrast, oral drugs undergo first-pass metabolism in the liver, reducing bioavailability. Other routes, like sublingual, transdermal, and inhalation, can bypass the liver and offer higher bioavailability than oral administration. (B) Drug formulation The physical and chemical properties of a drug, including its solubility, stability, and release mechanism, influence how much of the drug is absorbed and becomes available in circulation. For example, extended-release formulations are designed to release the drug slowly, potentially reducing its peak concentration but prolonging its effect. (C) Patient's age Age affects bioavailability because absorption, metabolism, and excretion change with age. In neonates and elderly patients, liver metabolism and renal clearance may be reduced, leading to higher drug levels and prolonged effects. Conversely, in younger adults, metabolism is generally more efficient, which can alter drug bioavailability.",
      "correct_choice_id": 257091,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71261981727532099/71261981727532099.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71261981727532099/71261981727532099.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89121,
      "choices": [
        {
          "id": 257092,
          "text": "Clearance"
        },
        {
          "id": 257093,
          "text": "Volume of distribution"
        },
        {
          "id": 257094,
          "text": "Half-life"
        },
        {
          "id": 257095,
          "text": "Bioavailability"
        }
      ],
      "text": "Which pharmacokinetic parameter is defined as the time it takes for the plasma concentration of a drug to reduce by half?",
      "unique_key": "Q8389564",
      "question_audio": null,
      "question_video": null,
      "map_id": 34330120,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Half-life. Half-life (t?/?) is the pharmacokinetic parameter that defines the time required for the plasma concentration of a drug to decrease by 50%. It is crucial in determining dosing intervals, drug accumulation, and the time required to reach steady-state concentration. The half-life depends on both clearance (CL) and volume of distribution (Vd), as expressed in the equation: t1/2 = 0.693 × Vd / CL Drugs with a short half-life (e.g., adenosine, nitroglycerin) require frequent dosing or continuous infusion, while drugs with a long half-life (e.g., amiodarone, diazepam) stay in the body longer and need less frequent dosing. Explanation of Incorrect Options: (A) Clearance Clearance (CL) is incorrect because it refers to the rate at which a drug is removed from the plasma via metabolism (liver) or excretion (kidneys). While clearance influences half-life, it does not measure how long it takes for drug concentration to reduce by half. (B) Volume of distribution Volume of distribution (Vd) is incorrect because it describes how extensively a drug distributes into body tissues relative to plasma. A drug with a high Vd (e.g., lipophilic drugs like amiodarone) is widely distributed in tissues, while a drug with a low Vd (e.g., aminoglycosides) remains mostly in plasma. (D) Bioavailability Bioavailability (F) is incorrect because it refers to the fraction of an administered drug that reaches systemic circulation in its active form. It is particularly important for oral drugs, where first-pass metabolism can reduce the amount that enters the bloodstream.",
      "correct_choice_id": 257094,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45109791727532143/45109791727532143.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45109791727532143/45109791727532143.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89122,
      "choices": [
        {
          "id": 257096,
          "text": "High first-pass metabolism"
        },
        {
          "id": 257097,
          "text": "High solubility"
        },
        {
          "id": 257098,
          "text": "Low protein binding"
        },
        {
          "id": 257099,
          "text": "Rapid gastric emptying"
        }
      ],
      "text": "Which of the following factors can significantly decrease the bioavailability of an orally administered drug?",
      "unique_key": "Q7229202",
      "question_audio": null,
      "question_video": null,
      "map_id": 34157741,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) High first-pass metabolism. Bioavailability refers to the fraction of an orally administered drug that reaches systemic circulation in its active form. When a drug undergoes extensive first-pass metabolism, it is metabolized by the liver before reaching systemic circulation, significantly reducing its bioavailability. Drugs like propranolol, nitroglycerin, and morphine have high first-pass metabolism, meaning a large portion of the dose is broken down before it becomes effective. This is why some drugs with high first-pass metabolism are given through non-oral routes (e.g., sublingual, IV, or transdermal) to bypass the liver and increase bioavailability. Explanation of Incorrect Options: (B) High solubility This is incorrect because high solubility generally enhances absorption, leading to higher bioavailability. Drugs need to dissolve in gastrointestinal fluids before they can be absorbed into the bloodstream. Poorly soluble drugs (e.g., griseofulvin) often have lower bioavailability, requiring formulation strategies (e.g., micronization) to improve absorption. (C) Low protein binding This is incorrect because protein binding affects drug distribution, not bioavailability. Drugs that are highly protein-bound (e.g., warfarin, phenytoin) remain inactive while bound and only the free (unbound) fraction is active. However, protein binding does not influence how much of the drug enters the bloodstream after oral administration. (D) Rapid gastric emptying This is incorrect because faster gastric emptying generally increases drug absorption. When the stomach empties quickly, the drug reaches the small intestine faster, where most absorption occurs. Conversely, delayed gastric emptying (e.g., due to fatty meals or gastroparesis) can slow down drug absorption and reduce bioavailability.",
      "correct_choice_id": 257096,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34544091727532169/34544091727532169.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34544091727532169/34544091727532169.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89123,
      "choices": [
        {
          "id": 257100,
          "text": "Drug solubility and stability in gastric fluid"
        },
        {
          "id": 257101,
          "text": "The first-pass effect by the liver"
        },
        {
          "id": 257102,
          "text": "Gastrointestinal motility"
        },
        {
          "id": 257103,
          "text": "All of the above"
        }
      ],
      "text": "Which of the following factors significantly influences the bioavailability of a drug administered orally?",
      "unique_key": "Q8013367",
      "question_audio": null,
      "question_video": null,
      "map_id": 34662293,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All of the above. Bioavailability refers to the fraction of an orally administered drug that reaches systemic circulation in an active form. Several factors influence bioavailability, including drug solubility and stability in gastric fluid, first-pass metabolism, and gastrointestinal motility. Each of these factors can either enhance or reduce the amount of drug that becomes available for therapeutic action. Drug solubility and stability in gastric fluid – For absorption to occur, a drug must be soluble in gastrointestinal (GI) fluids. Poorly soluble drugs (e.g., griseofulvin) have lower bioavailability, whereas highly soluble drugs dissolve readily and are absorbed more efficiently. Stability in gastric fluid is also crucial; drugs that degrade in acidic environments (e.g., penicillin G, omeprazole) may have reduced bioavailability unless formulated with enteric coatings. First-pass effect by the liver – After oral administration, drugs are absorbed through the gastrointestinal tract and enter the hepatic portal circulation, where they may undergo first-pass metabolism in the liver. This reduces the active drug concentration before it enters systemic circulation. Drugs with high first-pass metabolism (e.g., propranolol, morphine, nitroglycerin) have significantly reduced bioavailability and may require alternative routes (e.g., sublingual, IV) to bypass hepatic metabolism. Gastrointestinal motility – The rate at which the stomach empties and the intestines move affects drug absorption. Rapid gastric emptying allows the drug to reach the small intestine faster, where absorption is more efficient. Conversely, delayed gastric emptying (due to food, certain drugs, or conditions like gastroparesis) can slow absorption and reduce bioavailability. Explanation of Incorrect Options: (A) Drug solubility and stability in gastric fluid This is incorrect as a standalone answer because, while solubility and stability are important, they are not the only factors affecting bioavailability. Other factors like metabolism and motility also play a role. (B) The first-pass effect by the liver This is incorrect as a standalone answer because first-pass metabolism affects many drugs, but not all drugs undergo significant first-pass metabolism. Some drugs (e.g., levothyroxine, metformin) have minimal first-pass metabolism and retain high bioavailability. (C) Gastrointestinal motility This is incorrect alone because, while gut motility influences absorption, it does not solely determine bioavailability. Factors like enzymatic degradation, first-pass metabolism, and formulation are also crucial.",
      "correct_choice_id": 257103,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24886271727532282/24886271727532282.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/24886271727532282/24886271727532282.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 89124,
      "choices": [
        {
          "id": 257104,
          "text": "Increased effectiveness of an analgesic due to a sedative"
        },
        {
          "id": 257105,
          "text": "Antagonism of drug action by another drug"
        },
        {
          "id": 257106,
          "text": "Decreased absorption of one drug due to the presence of another"
        },
        {
          "id": 257107,
          "text": "Allergic reaction to a medication"
        }
      ],
      "text": "Which of the following is an example of a pharmacokinetic interaction?",
      "unique_key": "Q7959126",
      "question_audio": null,
      "question_video": null,
      "map_id": 34415775,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Decreased absorption of one drug due to the presence of another. A pharmacokinetic interaction occurs when one drug affects the absorption, distribution, metabolism, or excretion (ADME) of another drug, altering its concentration in the body. Absorption interactions can occur when one drug binds to another in the gastrointestinal (GI) tract, reducing its absorption. Example: Calcium supplements can bind to tetracycline antibiotics, decreasing their absorption and effectiveness. Metabolism interactions happen when one drug induces or inhibits liver enzymes (e.g., cytochrome P450 enzymes), affecting the metabolism of another drug. Example: Rifampin induces CYP3A4 enzymes, increasing the metabolism of oral contraceptives and reducing their effectiveness. Excretion interactions occur when drugs affect renal elimination, leading to changes in drug levels. Example: Probenecid inhibits the renal excretion of penicillin, prolonging its action. Explanation of Incorrect Options: (A) Increased effectiveness of an analgesic due to a sedative This is incorrect because this describes a pharmacodynamic interaction, not a pharmacokinetic one. A sedative (e.g., benzodiazepine) enhancing the effect of an analgesic (e.g., opioid) occurs due to additive or synergistic effects on the central nervous system (CNS), not because of changes in drug metabolism or absorption. (B) Antagonism of drug action by another drug This is incorrect because antagonism occurs when one drug opposes or reduces the effect of another drug at its target site, which is a pharmacodynamic interaction. For example, naloxone reverses the effects of opioids by blocking opioid receptors, but it does not alter the metabolism or excretion of opioids. (D) Allergic reaction to a medication This is incorrect because an allergic reaction is an immune-mediated response, not a pharmacokinetic interaction. Allergic reactions involve hypersensitivity to a drug, leading to symptoms like rash, swelling, or anaphylaxis, but they do not involve changes in the ADME processes of the drug.",
      "correct_choice_id": 257106,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63946691727532355/63946691727532355.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63946691727532355/63946691727532355.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}